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SUMMARY 
In recent decades, magnetic nanoparticles (MNPs) have received increasing attention 
in bio-related research, especially in the field of biocatalysis. This is due to several 
distinct properties, which are high surface area to volume ratio, special magnetic 
behavior, high dispersibility, and various functionalities. Immobilization of enzymes 
on functionalized MNPs could give the nano-biocatalyst with maintained free enzyme 
activity, higher stability, and easy recyclability under external magnetic field. This 
thesis developed novel methods for fabricating active, stable and recyclable nano-
biocatalysts, and the application of new types of nano-biocatalysts for green oxidation 
and biodiesel production. 
 
First, chloroperoxidase was covalently attached on polymer coated MNPs. A multiple 
core-shell structured particle (90 nm) was synthesized by co-precipitation followed by 
and in situ polymerization. The synthesized particles were modified with amino group, 
and the surface lysine of chloroperoxidase was applied for immobilization via linking 
by glutaraldehyde. The immobilized enzyme maintained the free enzymatic activity 
and showed good catalytic property in enantioselective sulfoxidation of thioanisole. 
The thick polymer shell significantly increased the stability of the nano-biocatalyst, 
giving no loss of activity after recycling for 11 times. It was the first example of a 
nano-biocatalyst for asymmetric oxidation, and the new concept could be generally 
applicable for fabricating active and recyclable nano-biocatalysts.  
 
Second, a histidine-tagged epoxide hydrolase (EH) was immobilized on Ni-NTA 
modified MNPs via affinity attachment. The MNPs (80 nm) was functionalized with 
Ni-NTA group. EH with was selectively purified from cell free extract including 
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other proteins impurities, and it was immobilized on Ni-NTA-MNPs. A racemic 
resolution with hydrolysis of racemic 2-(4-chlorophenyl)oxirane was used to verify 
the activity of EH. It was found that 80 % of the free enzyme activity was maintained. 
The final product was also purified in > 99 % ee. After recycling for 8 times, there 
was 80 % of initial enzyme activity left in the reaction system. This was the first 
example to use MNPs for one-pot purification and immobilization of EH in 
enantioselective hydrolysis. This concept could be generally used to develop stable 
and recyclable catalytic system with purification in one pot.  
 
Third, lipase was immobilized on five different MNPs (50 nm-300 nm) at two 
different temperatures for solving the problem of high acid content in grease trap oil 
for biodiesel production. Physical adsorption, covalent binding based on Schiff 
reaction, and a hybrid protocol combined both of adsorption and covalent interaction, 
were applied to optimize the immobilization protocol. The highest loading capacity 
reached to 200 mg lipase/g MNPs, which was two times higher than a 
commercialized enzyme-Novozym 435. These nanoparticles with immobilized lipase 
were further used for esterification of free fatty acid (FFA) in the waste oil. It was 
found that more than 95 % of FFA could be transformed into fatty acid methyl ester 
(FAME) within three hours with only 1 % w/w nano-biocatalyst in the grease trap oil. 
It was also reused and recycled for six times, and no dramatic decrease of the enzyme 
activity was found. This approach showed the advantages in using nanoscale catalyst 
in biodiesel production.  
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1 INTRODUCTION 
 
This chapter includes a brief introduction of research background, motivation, thesis 
objectives and thesis organization.  
 
1.1 Research Background and Motivation 
 
Biocatalyst, including isolated free enzyme, immobilized enzyme and whole-cell 
system, is on the verge of significant growth in chemical and pharmaceutical 
synthesis.
1
 It could perform exquisite regioselective and stereoselective syntheses to 
assist in forming complex molecules of industrial interest.
2
 This process does not 
require tedious blocking and deblocking steps in the common organic syntheses, and 
makes enzyme as an environmentally benign alternative to the conventional chemical 
catalyst.
3
 Besides, in most commercial biocatalytic processes, high product 
concentration and yield can be achieved with less or no undesirable by-products 
under much milder reaction conditions than their chemical counterparts. 
 
Comparing with the whole-cell systems, the use of enzymes in vitro leverages the 
positive effects by performing much cleaner reactions. This will further benefit 
product on-line detection and analysis, minimize undesired by-products formation, 
and facilitate product purification. Nevertheless, the free isolated enzyme system 
suffers from the problems of enzyme deactivation, poor enzymatic stability in terms 
of pH and temperature, and difficulty in reuse and recycle of the biocatalyst. 
Immobilizing enzyme on solid supporting materials could overcome these drawbacks 
by providing a rigid backbone. 
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In conventional immobilization process, mesoporous-structured beads (> 100 μm) 
and flat surfaces are generally applied. However, mass transfer limitation of reactants 
and products, poor dispersibility of the loading materials in catalytic systems, and the 
limited loading capacity are the major problems. To address these challenges, 
magnetic nanoparticle has been developed as a supporting material. Nano-sized 
structure enhanced mass transfer in catalysis and significantly improved loading 
capacity of enzymes. The magnetic property enabled efficient recovery of the 
immobilized enzyme after each use.  
 
Two key points, stability and functionality, should be considered in particle 
fabrication. In order to avoid any unwanted leakage or oxidation of magnetic core for 
achieving long-term stability, MNPs with stable surface coating materials are 
required. In the following bio-applications, especially during recycling and reuse, the 
stability of the whole system is crucial. It could be achieved by fabricating 
nanoparticles with suitable coating layers, stabilizers, and surface charge after loading 
of the enzyme. Second, for immobilization of enzymes onto the nanoparticles, proper 
functional groups should be designed on the particles for further chemical 
modification. To achieve good enzymatic activity, functional groups should be 
dedicatedly designed, considering surface property of the target enzymes and the 
location of their active centers. 
 
In shorts, particle surface chemistry should be customized for each biocatalytic 
system. However, at the beginning of this study, there was no commercial magnetic 
nanoparticle with those desired properties in terms of size and surface functions, 
which were suitable for our research in fabricating nano-biocatalyst. It was thus 
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necessary to develop a particle system with ideal stability and functionality in 
biocatalysis.  
 
In addition, traditional enzyme immobilization methods suffered severe problems, 
one of which was pre-purification. This means that enzyme should be purified by 
column (eg. FPLC) or gel before immobilization. Regardless of immobilization 
protocols (adsorption, covalent bonding, or entrapment), pre-purification of enzyme 
was always required, with the purpose of achieving good loading capacity of target 
enzyme on supporting material, and to avoid any unwanted side reaction in further 
catalysis. This procedure could be tedious, time-consuming and costly. Enzyme may 
also lose its activity in these purification steps. It will be ideal to develop a protocol to 
avoid this purification step and maintain similar biocatalytic performance. 
 
Considering applications of nano-biocatalyst, bio-pharmaceutics and bio-energy are 
interesting research areas, as these sectors require high performance of the catalysts, 
and the traditional biocatalysts or chemical catalysts may not fulfill the task. The use 
of nanoscale systems could solve the typical problems in these fields, eg. poor 
loading capacity, decreased activity after immobilization. Therefore, this technology 
has the potential to be commercialized with industrial partners in future.  
 
1.2 Thesis Objectives 
 
The overall objective of this thesis is to develop novel functionalized MNPs systems 
for effective immobilization of enzymes to achieve high stability, activity and 
reusability in nano-biocatalysis, in the fields of enhanced pharmaceutical synthesis 
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and sustainable clean energy production. Specifically, this research work comprises 
of the following three sub-objectives. 
 
1.2.1 Synthesis and Functionalization of MNPs 
 
The methodology for synthesizing MNPs will be explored. The desired nanoparticle 
should be stable, magnetic separable, and functional with the targeted size from 20 
nm to 500 nm. Several different methods for stabilizing nanoparticles will be applied, 
with consideration of further functionalities and applications. A series of 
nanoparticles with versatile functions and different structures (eg. multiple core-shell 
or watermelon) will be synthesized and characterized.  
 
1.2.2 Methodology for Immobilization of Enzymes 
 
Enzymes will be attached on the surface of MNPs to achieve the best catalytic 
performance by selecting the binding forces among van der Waals force, hydrophobic 
interaction, affinity force, and covalent force. In order to avoid tedious enzyme 
purification process before immobilization, a novel one-pot purification and 
immobilization technology will be studied. Theoretical calculation based on the size 
and functionality of nanoparticles will be demonstrated.  
 
1.2.3 Nano-biocatalysis and Related Applications 
 
Nano-biocatalysis, a new-emerging field, will be researched. In the part of enhanced 
pharmaceutical synthesis, several chiral building blocks will be synthesized by 
enzymatic methods, and oxidative chiral synthesis by magnetic nano-biocatalyst will 
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be the main component in this study. In the part of sustainable clean energy 
production, biodiesel production from the feedstock grease trap oil using recyclable 
nano-biocatalyst will be studied to meet the technical challenges. 
 
1.3 Thesis Organization 
 
This thesis comprises seven chapters. Chapter One provides a brief introduction, 
motivation, and objectives of this thesis. In Chapter Two, an in-depth literature 
review on the state-of-the-art technology related to MNPs and the novel concept of 
nano-biocatalyst is provided. Chapter Three presents the detailed material and 
methods used in this thesis to accomplish the experiments. The following three 
chapters show the results and detailed discussion achieved from the experiments. 
Specifically, in Chapter Four, chloroperoxidase covalently attached on MNPs for 
sulfoxidation is studied. A new methodology for one-pot attachment of his-tag 
epoxide hydrolase is presented in Chapter Five. Chapter Six presents the application 
of nano-biocatalyst in synthesizing biodiesel from waste grease trap oil. Finally, 
Chapter Seven summarizes the findings and conclusions from Chapter Four to 
Chapter Six, as well as gives recommendations for future work. 
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2 LITERATURE REVIEW 
 
This chapter reviews the current research progress on magnetic nanoparticles, 
protocols for immobilization of enzymes, and applications in nano-biocatalysis. 
 
2.1 Introduction of MNPs 
 
In the past few decades, nanotechnology draws increasing attention both from 







 and chemical properties, which could be hardly obtained for their 
bulk materials. The rapid development of nanotechnology brings us new 
opportunities for many applications, especially for bio-applications. Among these 
research and industrial process, the usage of MNPs brings new horizon for many 















 were all reported by researchers in different research 
field. Among these materials, iron oxide MNPs, generally including maghemite (γ-
Fe2O3) and magnetite (Fe3O4) nanoparticles are promising for their biocompatible 
features, low cost, as well as relatively simple synthetic procedures compared with 
other magnetic materials. Conventionally, the synthetic methods of iron oxide MNPs 
could be classified into five categories: co-precipitation, microemulsion, thermal 
decomposition, hydrothermal methods, and sol-gel methods.
13
 Details will be 
presented in § 2.1.2, respectively. 
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Suitable functionalization of MNPs could also play an essential role for further 
syntheses and applications. On one hand, the coating layer will protect those particles 
from undesired aggregation and make particles much more stable when exposing to 
oxygen or high salted buffer solutions. On the other hand, coating or grafting on the 
surface of the metallic particles will bring unique features to the nano-system, which 
provides the possibility for further applications, especially in the process of recycle. 
 
2.1.1 Special Properties of MNPs 
 
The iron oxide magnetic nanoparticle with small size possesses unique features. 
Single domain limit and large surface areas are the two conspicuous properties. In 
addition, the magnetic core endues the particles with magnetic properties. For 
applications in bio-related areas, especially in vivo, biocompatible iron oxide MNPs 
are favored. Besides, for in vitro applications, biocompatibility of nanoparticles could 
help to maintain the original feature of biomolecules, including tissues, cells or 
proteins. 
 
2.1.1.1  Single Domain Limit 
 
Single domain limit is the most important feature for finite-size effect.
13
 When the 
size of MNPs is small enough, it is possible to just possess single magnetic domain in 
one particle. The critical diameter (Dc) of a spherical particle model could be 
calculated by Equation 2-1 as below: 
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Where A is exchange constant, Keff is anisotropy constant, μ0 is vacuum permeability, 
and M is saturation magnetization. The Dc value of Fe3O4 is 128 nm.
14
 A single-
domain particle is uniformly magnetized with all spins aligning in the same direction. 
That is the reason for the existence of very high coercivity.
15
 Single magnetic domain 




2.1.1.2  Large Surface Areas 
 
With the decrease of particle size, the surface area to volume ratio of MNPs increases 
greatly which result in larger effective area of nanoparticles for functionalization. 
Comparing a nanoparticle (100 nm in diameter) with a bead (100 μm in diameter) of 
the same material, the 100 nm nanoparticles have 10
6
 times more surface area.  In 
addition, the effect of surface and interface becomes important as compared to bulk 





2.1.1.3  Magnetic Properties 
 
The properties of magnetic particles can be divided into two major categories: 
paramagnetic and ferromagnetic. The difference between them is that after removing 
the external magnetic field, the presence of the magnetized materials is different. No 
residual magnetism exists for paramagnetic particle, whereas certain residual 
magnetism exists for ferromagnetic particle. The properties of the magnetism are 
generally decided by the particle size distribution and the blocking temperature.  
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The superpara-magnetic particle is a mixture of paramagnetism and ferromagnetism. 
It has no magnetism when the external magnetic field is removed. However, at very 
low external magnetism, it will reach to the saturation magnetism. When separating 
magnetic particles from the mixture by normal magnet, this superpara-magnetic 
property would help to facilitate the separation to be fast and efficient. 
 
2.1.1.4  Biocompatible Features 
 









Kral17 Fe3O4 PEO/C18 70 nm CHO mammalian cell slightly toxic 
Pisanic 
Ii18 
Fe2O3 naked 8 nm neural cell 
dose-
dependent 




Karin20 Fe3O4 dextran 30 nm 
human monocyte 
macrophages 
not toxic in 
vitro 
 
With the purpose of applying particles in bio-related areas both in vivo and in vitro, 
the MNPs must be biocompatible and non-toxic after modification. This could be 
gained by coating or grafting with certain materials on the surface of the particles 
during or after synthesis. This requirement brings new challenges for synthesis and is 
closely related to the further application. Several experiments have been done to test 
the biocompatibility and toxicity of these modified nanoparticles. Table 2-1 exhibits 
results of related experiments. It can be observed that iron oxide nanoparticles did not 
present strong toxicity after coating with biocompatible polymer layers. These studies 
are generally performed in vivo. As for in vitro applications, biocompatibility is also 
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important.
21
 This ensures that proteins or cells will not denature upon contacting with 
MNPs. This is the foundation for further interaction via covalent binding, affinity 
binding or physical adsorption. 
 
2.1.1.5  Structures of Iron Oxide 
 
The structure of γ-Fe2O3 is based on hexagonal close packing of oxygen with iron in 
2/3 of the octahedral vacancies. The lattice parameters are: a = 5.038 Å, c = 13.772 
Å. The space group is (S.G. 167) R32/c. At low temperature it is antiferromagnetic 
with spins oriented along the electric field gradient axis. When the temperature is 
raised to about 260 K, a spin flop transition (known as the Morin transition) occurs 
and the spins shift by about 90° becoming canted to each other. This transition results 




Magnetite (Fe3O4) is a common form of magnetic iron oxide, and it has a cubic 
inverse spinel structure with oxygen forming a FCC closed packing and Fe cations 
occupying the interstitial tetrahedral sites and octahedral sites.
23





 ions in the octahedral sites at room temperature, rendering 




2.1.2 Synthetic Methods of MNPs 
 
The synthesis of MNPs has been intensively studied by researchers. Several physical 
or chemical synthetic methods could be applied with controlled conditions. Table 2-2 
presents the comparison of different methods with respect to reaction parameters, size 
distribution, shape control, and magnetization value. 
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As can be seen from this table, co-precipitation is the easiest way to synthesize iron 
oxide MNPs with high yield, when the size distribution and shape is not very strict. 
Microemulsion could be a promising method for its good overall performance. 
 












surrounding aqueous organic organic aqueous aqueous 
pressure normal normal normal high normal 
temperature (ºC) 20-90 100-320 20-50 160-300 40-400 
reaction time minutes hours-days hours hours hours 
size distribution broad very narrow narrow very narrow broad 
shape control bad perfect good perfect perfect 
magnetization (emu/g) 20-50 20-60 >30 10-30 10–40 
complication  very simple complicated complicated simple simple 





Co-Precipitation is a simple way for synthesizing the iron oxide MNPs for its 
relatively easy procedure, short reaction time and mild reaction condition. Generally, 
ferric and ferrous salts are added into reactor and followed by a base, which could 
provide OH
-
 group for the reaction. Super-saturation of iron oxide reaches due to the 
chemical reaction, and nucleation of iron oxide crystals will be accomplished in a 
short time. With the protection of surfactant or other particle stabilizer, the size of the 
crystals can be controlled in nano-range without growing bigger. The overall 
chemical reaction regime could be summarized in Equation 2-2 as below.
29,30
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       (Equation 2-2) 
 
However, a side reaction would occur at the presence of oxygen in the system. Fe3O4 




        (Equation 2-3) 
 
Conventionally, bubbling inert gas (nitrogen or argon) into the reaction system could 
be a practical way to avoid further oxidation of Fe3O4. Besides, it was reported that 
these bubbles could not only sharply decrease the undesired oxidation, but also would 




During or after the precipitation, stabilizer could be added to avoid forming 
agglomerate. Detailed method will be discussed in § 2.1.3.  
 
2.1.2.2  Microemulsion 
 
A microemulsion is defined as a thermodynamically stable isotropic dispersion of two 
immiscible liquid solvents, since the micro domain of either or both liquids has been 
stabilized by an interfacial film of surface-active molecules.
34
 The research on 
microemulsion method has made good progress during these years. The advantages of 





When water-in-oil microemulsion being applied, the oil phase is the continuous 
phase. The aqueous phase is dispersed as nano-droplets (typically 1–50 nm in 
OHOFeOHFeFe 243
23 482  
32243 )(35.425.0 OHFeOHOOFe 
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diameter) surrounded by a monolayer of surfactant molecule. The size of the reverse 




When mixing two identical water-in-oil microemulsion containing the desired 
reactants, the micro-droplets will continuously collide, coalesce, and break again, and 
finally a precipitate forms in the micelles.
11
 Finally, by adding solvent like acetone or 
ethanol into the microemulsion, the newly formed precipitate could be extracted by 
filtering or centrifuging from the mixture.  
 
2.1.2.3  Thermal Decomposition 
 
Thermal decomposition performs well in synthesis of MNPs with controlled size. The 
precursors are generally organometallic compounds. They are added into high-boiling 
organic solvents containing surfactants.
11,37,38
 The growth of monodispersed MNPs 
occurs simultaneously with the decomposition at a high reaction temperature. This 
process is influenced by reaction time, temperature and the characteristic length of 
surfactant molecule. 
 
The oxidation process mainly accompany with the synthetic process. For exposure to 
atmospheric air is usually unavoidable, it is critical to control the reaction pathway 
and consequently to maintain the magnetic properties of the final product. A mixture 
of magnetite and maghemite in a fluctuant ratio is usually the result of such synthetic 
procedures. However, it is possible to favor the formation of only one of the oxides 




2.1.2.4 Hydrothermal Method 
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Hydrothermal method could synthesize wide size range particles from micro scale to 
nano scale with narrow size distribution. This method is based on phase transfer, as 
well as separation mechanism happening at the interfaces of the liquid, solid, and 




2.1.2.5  Sol-gel Method 
 
Sol-gel method is favored by several advantages compared with other methods. High 
purity and good homogeneity are two obvious features. Generally, the production of 
iron oxide uses metallorganic precursors.
39
 However, this method is always much 
complicated compared with precipitation. Furthermore, it calls for expensive and 
toxic reagents. This could not be applied in large-scale production. Equation 2-4 




 (Equation 2-4) 
 
2.1.3 Stabilization and Functionalization of MNPs 
 
The procedure of stabilization for iron oxide MNPs plays a key role both for synthesis 
and for further applications. The surface of iron oxide is hydrophobic. If the surface 
was not modified, the nanoparticles easily become agglomerate or get oxidized by 
oxygen or other distorted reagents. With proper coating, grafting or dispersed in 
certain matrix, the iron oxide MNPs could stably demonstrate special properties. This 
greatly prevents forming undesired agglomerate and maintains the stability of the 
system.  
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According to the coating materials, the stabilization could be classified into two 
major groups: organic coating and inorganic coating. In each group, there are several 
related methods. Detailed discussion is presented in the following sections. 
 
2.1.3.1  Organic Coating 
 
Organic coating is wildly used for stabilizing iron oxide MNPs. It often demonstrates 
good biocompatibility and stability. In general, surfactants or polymers can be 
physically adsorbed or chemically anchored on the surface of MNPs to form a single 
layer or double layers, which generates steric repulsive forces to balance the 
nanoparticles in solution.
40,41
 Both natural polymer and artificial polymer were used 
for this purpose. 
 
2.1.3.1.1  Polymer Coating 
 
Many polymers could be used for stabilization or functionalization of iron oxide 
















were also reported for surface modification of iron oxide MNPs. These modified 
particles with polymers on the surface generally exhibit good biocompatibility 
compared with other coating materials. However, the polymer coating will lead to the 
decrease of magnetism value of the iron oxide MNPs.  
 
2.1.3.1.2  Surfactant Coating 
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Surfactant could also be used to passivate the surface of the nanoparticles. Fatty acid 
is wildly used in this research area. Among them, oleic acid, which has a C18 (oleic) 
tail with a cis-double-bond in the middle, could form a kink structure. Such kinks 




2.1.3.2 Inorganic Coating 
 
2.1.3.2.1 Silica Coating 
 
Silica has good performance in stabilizing iron oxide MNPs. First, it prevents direct 
contact between magnetic core and avoids the unwanted interaction.
9
 Second, for 
synthesis of maghemite particle, silica matrix could perform as an anti-sintering 





Since the iron oxide surface has a strong affinity towards silica, no primer was 
required to promote the deposition and adhesion of silica. Owing to the negative 





2.1.3.2.2 Metal Coating 
 
Many metals could also be used for the coating on the surface of iron oxide MNPs. 
JitKang and coworkers reported that gold shell iron oxide MNPs exhibit strong 
plasmonic bands in their UV–visible absorption spectra. It provided a way to 
quantitatively characterize the separation effectiveness in situ.
53
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2.1.4 Bio-applications of MNPs  
 
With special properties, the MNPs could be used in several bio-related fields, 




Iron oxide magnetic nanoparticle is suitable for small scale bio-separation of 
biomaterials, such as DNA, antibody, enzyme, and cells. This is based on the use of 
high-gradient magnetic separation (HGMS) or permanent magnet, which is currently 




Magnetic resonance imaging (MRI) is one of the most powerful techniques in 
diagnostic clinical medicine and biomedical research,
54
 which is based on the 
principles of nuclear magnetic resonance
3
. Superparamagnetic iron oxide particles 
with larger magnetic moment, could be used as indicators of organ functions or blood 




M. P. Morales and coworkers reported that dextran-coated iron oxide nanoparticles 
aggregates with a hydrodynamic diameter of around 50 nm and unimodal size 
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The use of iron oxide MNPs is based on the high specific areas and magnetization, 
which provide electrochemical properties. This could be used for detecting 




2.1.4.4 Fermentation Enhancement 
 
Iron oxide MNPs with suitable coating could also be used for enhancing fermentation 
process. The organic coating layers could dramatically increase the solubility of 
oxygen in a viscous broth. The enhancement of oxygen mass transfer could largely 





and coworkers reported that the gas-liquid oxygen mass transfer increased up 
to 6-fold at the presence of iron oxide nanoparticles.
56
 Although maintaining good 
stability of the particles in the presence of high salt culture medium is still 




Hyperthermia is defined as the method for heating cancer cells with the purpose of 
cancer therapy. Recently, superparamagnetic iron oxide nanoparticles are reported as 
heating mediator for hyperthermia.
57
 Compared with normal paramagnetic materials, 
superparamagnetic magnetization possesses much higher magnetization saturation. 
After delivering into certain positions in human body, an outer magnetic field is 
applied. With the interaction between outer magnetic field and superparamagnetic 
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iron oxide nanoparticles inside body, the produced heat is sufficient to kill the cancer 
cells.  
 
Shinkai and coworkers reported that magnetite cationic liposomes could be used for 
hyperthermia.
58
 These nanoparticles have positive surface charges, and it has affinity 
to target rat glioma cells. 
 
2.2 Immobilization of Enzymes on MNPs 
 
Enzymes, as biological catalysts, promote the transformation of chemical species with 
high activity, selectivity and specificity. In spite of their excellent catalytic 
performance, free enzyme system suffers from several vital disadvantages.  
 
The major defects include the inhibition by high concentration of substrates and 
product, and low stability, activity and selectivity under harsh conditions. Therefore, 
immobilization of enzymes should be considered, in order to enhance their stability 
and catalytic performance in the unconventional and unnatural conditions. The 
reusability of the immobilized enzyme will also be economically feasible.  
 
2.2.1 Immobilization of Enzymes and Its Advantages 
 
2.2.2 Using Traditional Supporting Materials for Attaching Enzymes 
The traditional approaches for immobilization of enzymes could be divided into two 
major categories: irreversible methods and reversible methods.  
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Table 2-3 Approaches of enzyme immobilization 
Irreversible methods Reversible methods 
Covalent binding Adsorption 
Entrapment Ionic binding 
Microencapsulation Affinity binding 
Crosslinking Disulfide bonds 
 Chelation or metal binding 
 
    
Mesoporous structured beads and flat surface were generally used for enzyme 
immobilization. However, several problems are still remaining. Firstly, the poor 
dispersibility of support with the immobilized enzymes limits mass transfer of 
substrates, which are difficult to reach to the vicinity of the enzyme surface. As a 
result, the productivity of the catalysis will drop. Secondly, when solid impurities 
such as cell debris or solid substrates exist, it is not easy to recycle the immobilized 
enzymes from the reaction mixture. The reusability will also be decreased. Thirdly, 
enzyme loading capacity is always restricted by the limited surface area of the 
traditional support. If more enzymes could be loaded on the support, the apparent 
activity of enzyme will be increased.  
 
2.2.3 Immobilization of Enzyme on Novel Nanomaterials 
 
Immobilization of enzymes on nano-structure holds significant importance. The 
immobilization lies on two sides: the surface function of nano-structure and the 
special property of the enzyme. With the purpose of obtaining higher activity, the 
immobilization chemistry should be carefully selected. The chemistries for attaching 
enzyme on nanostructures were transplanted from the experience of using the 
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conventional micro-sized materials. Direct covalent bonding, physical adsorption, 
chelating interaction and entrapment were generally applied.  
 
Physical adsorption by Van de Waals force could be easily reached without any 
further chemical modification of the supporting materials. This is a generalized 
method and could be applied for most of enzyme and nano-support just by 
hydrophobic or hydrophilic interaction. The disadvantage is also obvious. The 
combination force is weak which leads to leaking of the enzyme during shaking in the 
reaction or during recycling. Compared with adsorption, entrapment of enzyme 
within a nano-structure has certain improvement in enhancing the interaction between 
the two components. However, it suffers mass transfer limitation and initial leaking of 
enzyme activity.  
 
Covalent bonding between enzyme and nano-support is more reasonable. The 
permanent bond between these two ensures a strong immobilization. Leaking will not 
be a problem. The mass transfer problem will also be solved if the enzyme is loaded 
on the particle surface. The nano-surfaces have been modified with versatile 
functional groups in order to adapt to different enzyme system. New endeavors are 
still on-going for developing better nano-biocatalytic system. However, if the 
immobilization is random, the orientation of enzyme could not be controllable, which 
will results in fast decrease of enzyme activity after immobilization. This protocol 
also requires that the enzyme possess active functional groups on surface such as –
NH2, -COOH, -SH etc. 
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Figure 2-1 Chemistry of enzyme immobilization on nano-size surface 
 
Recently, there are new technologies for immobilization of enzyme on nano-
structures with the fast development of genetic engineering.
60-62
 It is possible to 
modify enzyme with certain terminal tags without compromising its activity. His-tag 
is one of the wildly used tags. Six or eight histidines could be introduced to the N or 





. In order to attach the tagged enzymes, the surface of the nano-









or directly modified with NiO.
70
 These modified nanostructures could effectively 
capture his-tagged enzyme in a mixture of proteins with high selectivity and 
efficiency. Another tag is based on the interaction of C-intein and N-intein modified 
on the enzyme and nano-carriers separately.
71,72
 The two peptides could interact with 
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each other and acquire function to cut down them. Consequently, the enzyme will be 
covalently bonded on the nano-carriers surface. 
 
As other nano-materials, magnetic nano-carriers possess extreme high surface area to 
volume ratio. This is a superior feature over micro-size support, where the enzyme 
loading capacity was limited and thus may become a barrier to reach the best 
performance. It is obvious that based on simple calculation that surface area to 




) than that of 
micro-size material. Even though, it is suggested that the enzyme on particle should 
not be too crowded in order to reach to the best performance.  
 
 
Figure 2-2 Comparison of immobilization between nano-size surface and flat surface 
 
Besides, the surface curvature is also different in these two scenarios shown in Figure 
2-2. Enzyme (eg. with molecular weight of 80 kDa) has a size dimension of about 10 
nm, and is generally considered with a globular shape. When free enzyme 
approaching the target micro-sized surface, the interaction area is rather big since the 
surface is much flat. It has been reported that enzyme needs to flatten itself with 
changes of its secondary structure.
73
 On the contrary, the nanoparticle for 
immobilization generally lies in the range of 10 nm to a few hundred nanometers. 
When enzyme approaching nano-sized surface, it could maintain its original structure 
since the interaction area is limited with a high curvature of the particle surface. 
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Enzyme stability towards pH, temperature and organic solvent could generally be 
improved after immobilization by fixing its 3D structure or by providing shields from 
contacting with external conditions.  
 
For bonded enzyme on nano-structured surface exposed to the solvent without any 
barrier, it may suffer from higher shear stress compared with enzyme embedded in 
mesoporous structure in micro-sized beads under the same controlled conditions. This 
is because that it is reported that hydrodynamic stresses can deform polymer 
nanoparticles, and to stretch and squeeze it,
74
 while mesoporous structured beads may 
not surfer the same phenomena as the enzymes are inside pores. 
 
In order to maintain high activity of the enzyme during catalysis, the bonding point 
should not be too many. However, one point immobilization may not be strong 
enough to fix the enzyme configuration under extreme conditions. For enzyme 
encapsulated inside nano-sized structure, the improvement towards harsh condition 
should be better, but with a high mass transfer problem. This dilemma needs further 
research effort. A study on multi-point site-specific attachment may be a good 
direction.  
 
2.2.4 MNPs as Enzyme Supporting Materials 
 
As described before, MNPs possess special properties compared with their bulk 
materials. First, the biocompatibility of nanoparticle with enzyme is the pre-condition 
for enzyme immobilization, which guaranties enough residual activity before 
immobilization occurs. Second, compared with traditional supports, high surface 
areas of MNPs solved the problem of limited enzyme loading capacity. Third, 
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functionality of the MNPs provides versatile attachment protocols to meet the needs 
of all kinds of enzymes. Fourth, particles with small size result in high dispersity, so 
the mass transfer limitation of the substrates and products will be minimized. Fifth, 
good stability of the MNPs will also be achieved by proper coating on the surface. 
Finally, the superparamagnetic properties of the particles allow the easy separation of 
immobilized enzymes by applying external magnetic field.  
 
Recently, several researchers devoted their efforts into this research area, applying 
functionalized MNPs for enzyme immobilization. Their research focuses are listed as 
follows. 
 
2.2.4.1 Stability and Activity of the Immobilized Enzymes 
 
In order to use immobilized enzymes for industrial applications, high stability and 
activity of the enzymes are essential. These two factors are greatly influenced by the 
environmental factors and enzymes used in immobilization protocols. After 
immobilizing enzymes on MNPs, the stability of the enzyme is generally increased 
against the change of pH, temperature and organic solvent. However, the activity 
drop is always observed by random amide bond or Schiff base formation, which 




Yang and coworkers attempted to use enzyme encapsulation by MNPs to solve this 
problem.
76
 Glucose oxidase was used as a model enzyme. Enzyme is capsulated 
inside the shell containing iron oxide and poly (pyrrole-N-propylsulfonic acid) 
composites. The caged single-enzyme nanoparticles maintained good activity 
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compared with free enzyme with the change of pH, organic solvent and high 
temperature.   
 
Site-specific immobilization is also considered as an effective approach to maintain 
the enzyme activity. Yu and coworkers reported that CMP-sialic acid synthetase 
(CSS) was site-specifically immobilized on cysteine-functionalized MNPs obtained 




The stability of the catalytic system is quite important. First, the stability of the 
catalytic system could be evaluated from the point of particles themselves, which 
means that around the naked iron oxide crystals, proper protection is required to avoid 
any non-favored aggregation. These naked particles with immobilized enzymes tend 
to aggregate during magnetic separation and redispersion cycles, which will result in 
partial loss of the enzymatic activity due to the limited accessibility of substrate 
molecules. Rossi and coworkers applied ammonium persulfate modified iron oxide 
MNPs to immobilize glucose oxidase.
78
 However, the suspension lost 50 % of its 
original activity after five runs. Furthermore, silica coated MNPs were intensively 
studied for immobilizing enzymes. Most of them applied amino group functionalized 
silica particles to attach enzymes. Silica may behave as a protection layer to avoid the 
aggregation of iron oxide and help to increase the catalyst stability to some extent, but 
the obtained stability was not sufficient enough for efficient recycling and reuse of 
the catalyst. Gao and coworkers reported the research work, which have only shown 
the result after one recycle in supporting materials without providing detailed data for 
further recycling.
79
 Similarly, Lee and coworkers showed that when using covalent 
attachment to immobilize lipase on silica MNPs, they found continuous decrease of 
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activity during recycling.
80
 After 10 cycles, the final activity only reached to 60 % of 
its original. 
 
Second, the long-term stability of the catalytic system could also be judged on the 
immobilization method. Roughly, three methods are applied in current stage, which 
are covalent bonding, physical adsorption, and entrapment. Covalent binding 
generally provides enough force between enzyme and MNPs and permanently 
combines these two. On contrast, during physical adsorption, van der Waals force or 
hydrophobic interaction is the main force for attaching enzymes. This kind of 
attachment is temporary and the enzyme may leave the MNPs under harsh conditions 
during recycling. Lee and coworkers showed the results that lipase could be 
physically adsorbed on hydrophobic nanoscale magnetite particles.
81
 During 
recycling, they found that nearly half of the activity was lost after the first use. They 
also explained that this may be due to enzyme desorption from MNPs during the first 
reaction. There is also a report in using silica to conduct entrapment of immobilized 
enzyme. But like any other entrapment system without magnetic materials, the mass 
transfer problem of the substrate and the leakage of enzyme probably occur during 
reaction and recycling. Shukoor and coworkers applied Ni
2+
 as template to attract 
slicatein and then fabricated a silica coating on the catalytic system.
82
 However, they 
did not show any data regarding the long-term stability of the system.  
 
2.2.4.2 Magnetically Separable Nanoparticles with Immobilized 
Enzymes 
 
Easy separation by applying external magnetic field is a unique feature for enzymes 
immobilized on MNPs. With the purpose to get good separation efficiency, no 
residual magnetism for the particles is needed. Lee and coworkers studied the 
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synthesis of superpara-MNPs in the reverse-micelle solution.
80
 The resultant particles 
have uniform shape and the thickness of the silica shell. Furthermore, the MNPs, 
which size is smaller than 12 nm, could be easily controlled by a permanent magnet.  
 
2.2.4.3 High Dispersibility  
 
The high dispersibility is needed for minimizing the limitation of mass transfer. The 
hydrophilic polymer covering MNPs was synthesized by Hong and coworkers.
83
 This 
polymer was obtained by photochemical in situ polymerization. Lee demonstrated the 




2.2.4.4 Diverse Functionality 
 
The functional group on the surface could be diversified. There are lots of reports on 
the amine mediated functionalized MNPs.
77,80,84





2.3 Nano-biocatalysis and Its Novel Applications 
 
2.3.1 The Concept of Nano-biocatalysis 
 
Biocatalysis is an important technology for synthesizing fine chemicals, 
pharmaceutical intermediates as well as food and agrochemical ingredients.
1,86
 
Microbial cells, either growing cells or resting cells, as well as enzymes are generally 
applied for this process. Compared with chemocatalysis, using organometallic 
materials or inorganic ligands, the advantages of biocatalysis are obvious: 
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extraordinary regio- and enantioselectivity with good production yield, extreme high 
catalytic activity, rather low E factor (kg waste/kg product),
87
 and high turnover 
frequencies under benign reaction conditions. In recent years, inspired by the rapid 
growth of nano-biotechnology,
88
 biocatalysis provided new possibilities for obtaining 
the best performance. 
 
The individual word “nano-biocatalysis” is composed of three aspects: nano, bio and 
catalysis. The word “nano”, implies the dimension requirement of the catalytic 
system. There is a debate on-going with regard to the definition of “nano”. Some 
researchers claimed that only the dimension < 10 nm could be named as “nano”, 
where some materials (eg. gold) could possess special surface properties. In the field 
of biocatalysis, we believe that the dimension could be broadened into sub-micro, 
since a single enzyme itself is already in the dimension of 10 nm. In general, nano-
biocatalysis describes nano-materials supported enzymes and encapsulated enzymes 
within nanostructures for biotransformation and biocatalysis.  
 
 
Figure 2-3 Various supporting materials for fabrication of nano-biocatalyst 
 












 are the most prevalent choices. These different 3D nano-
structures could offer versatile nano-environment to facilitate enzymes in the vicinity 
to reach their best activities, as well as stabilities towards different catalytic systems. 
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The surface chemistry occupies the same importance as the nano-environment, which 
is brought by the materials of the nanostructures. Considering materials, 
nanostructures could be composed by single type of material as well as hybrid 











 are quite popular materials for fabricating nano-supports. Carbon 
nanotube for immobilizing enzymes,
92,93,115
 and DNA scaffold modified 
enzymes,
98,116,117
 are also hot zones in this research field. In order to further introduce 
versatile functionalities and better stability to the supporting nanostructures, hybrid 
nano-materials received more attentions during recent years. Iron oxide nanoparticles 









 for this application. These nanoparticles possess superior advantages: the 
magnetic materials could be used for facile separation, and the surface functions 
could be applied for attaching enzymes. For encapsulation of single enzyme or 
multiple enzymes, polymer and silica are widely investigated.  
 
 
Figure 2-4 Properties should be consider during immobilization 
 
Comparing traditional supports, the expectations for using these new nanomaterials 
are obvious. First, the immobilized enzyme in nanostructure should be stable enough 
under harsh conditions, such as in organic solvent, extreme pH, and high temperature. 
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Second, the immobilized enzyme should be easily separated from the reaction 
mixture containing solid and liquid wastes for facile purification of product. Third, 
the mass transfer limitation of substrate and product should be minimized in order to 
maximize the production yield. Fourth, the immobilized enzyme should maintain its 
catalytic properties after loading on the nano-support. Fifth, enzymes, which are 
generally expensive and rare, should be reusable and recyclable in order to cut down 
the cost for higher economic benefits. Figure 2-4 summarizes the properties which 
need to be considered during fabrication of the nano-biocatalyst.  
  
2.3.2 Fabrication of Novel Nano-biocatalyst with Chloroperoxidase 
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Figure 2-5 Three types of reactions catalyzed by CPO124 
 
Chloroperoxidase (CPO; EC 1.11.1.10) from Caldariomyces fumago has been 
investigated from its catalytic properties to its genetic sequences. ATCC 16373, 
Caldariomyces fumago, which is a filamentous fungus, could be a potential candidate 
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in producing CPO. CPO from this strain is an extracellular protein with molecular 
weight (MW) at 42 kDa. It consists of 300 amino acids and contains a heme. The 
catalytic properties of CPO are very attractive. Oxidation, epoxidation and 
sulfoxidation reactions could be performed by CPO. A lot of useful pharmaceutical 
intermediate could be produced by CPO. Figure 2-5 presents some examples for these 
three kinds of reactions.  
 
However, the industrial application of CPO was severely restricted by its extreme 
high expense, the difficulty of enzyme recovery after biotransformation,
125
 and the 




2.3.2.1  Immobilization of Chloroperoxidase 
 
In order to solve those problems, plenty of research efforts have been devoted to 















 were reported to be 
used for immobilizing CPO with increased enzyme stability. However, CPO could be 
easily peeled off from the pore wall due to the shear stress, which resulted in a 
continuous decreasing apparent activity during reaction or recycling.
133
 Furthermore, 
the internal mass transfer limitation may also restrict the performance of the 
immobilized enzyme. Much lower specific activity was generally observed after 
immobilization.
128
 Meanwhile, other researchers were trying to apply sol-gel method 
to encapsulate CPO inside the supporting matrix in order to obtain sufficient stability 
in the presence of hydrogen peroxide for conducting reactions.
104,125
 However, the 
major drawback of this method is the huge initial release of enzyme activity during 
aging of gels, which could be hardly avoided.
125
 More recently, covalent binding of 
Chapter 2 Literature Review                                                                                                       33 | P a g e  
CPO on several supports has been researched.
134-136
 Based on the isocyanate groups in 
polyurethane polymer, glycosylated CPO could be immobilized on the support. 
However, the activity decreased to 54 % of its original value and the immobilization 
efficiency decreased fast when increasing the enzyme loading on the support, and no 
recycling data was shown.
137
 Besides, silica gel and magnetic beads were also 
adopted as supporting materials for covalent immobilization of CPO.
138-140
 The major 
problems of these micrometric supports were the very low loading amount, generally 
below 3 mg CPO/g support, and the huge decrease of enzyme specific activity after 
immobilization.  
 
2.3.3 Site-specific Attachment of Enzymes on MNPs for Biocatalysis 
 
In recent years, site-oriented attachment of enzymes on functional supporting 
materials for bio-reaction is receiving increasing attention from researchers. Among 
different supports, nanoparticles are considered as versatile scaffolds to target enzyme 
surfaces via complementary interactions.
141
 This technology combines biotechnology 
and nanotechnology to develop enzyme-conjugated nano-materials in a highly 
specific intermolecular way.
89
 With comparison of conversional covalent binding 
protocol (eg. Schiff base reaction) and non-specific adsorption, site-specific 
attachment maintains enzyme activity and flexibility on the surface of nano-
supporting materials, with a defined and controlled arrangement of the enzyme. There 
are two major categories for site-specific attachment. One of them is a reversible 
protocol based on affinity tags, and the other one is non-reversible based on chemical 
binding.   
 
2.3.3.1 Reversible Site-specific Attachment of Enzyme by Affinity Tags 
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Site-specific purification of enzyme by using affinity tags is a general method in 
protein engineering. Tags can be fused into protein sequence, and the expressed 
peptide or enzyme could specifically bind with the modified purification matrix. 
There are several commonly used small affinity tags, such as His-tag, GST-Tag, 







 modified surface, is widely used due to its small size and less 
interference to the enzyme structure and function. It is reported that Cu-IDA/Ni-
NTA/Ni
2+
 modified MNPs could effectively attach his-tagged enzyme.
69,142
 The 
loading capacity could also reach a very high level. Besides, there are also other tags 
available. For example, Strep-tag (Trp-Ser-His-Pro-Gln-Phe-Glu-Lys) will interact 
with strep-tactin with intrinsic affinity.
143
 Besides, small proteins could also be fused 
into the target enzyme sequences to achieve site-specific immobilization.  Glutathione 
s-transferases (GST-Tag) with a molecular weight of 26 KDa, could interact with 
glutathione-based affinity resins. Maltose binding protein (MBP-Tag) could bind on 
amylose resins for protein purification. The fusion of these proteins can increase the 
solubility of the enzyme in aqueous phase, while due to the rather larger size, 
expression of fused protein-enzyme is problematic sometime. 
 
2.3.3.2 Non-reversible Site-specific Attachment of Enzyme  
 
For non-reversible site-specific attachment of enzyme, two methodologies can be 
generally applied, which are chemoselective and chemoenzymatic methods.
62
 
Chemoselective methods require the modification of particle surfaces. It also strongly 
relies on the concentration of the target enzyme. Several examples have been reported 
with the concept of chemoselective methods. Staudinger ligation reaction were 
applied by forming an amide bond between azide group on the protein and an 
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arylphosphine moiety on the particle surface.
144
 Expressed protein ligation was used 
based on the interaction between N-terminal Cys residue and a-thioester proteins.
145
 
Five tandem cysteine repeats (Cys-tag) fused at termini of enzyme, could also be a 
good way for attachment. It is shown that Cys-tagged EGFP could be captured on the 
maleimide-coated substrate efficiently.
146
 Click chemistry has also been used to 





For chemoenzymatic method, it introduces complementary moieties in the enzyme 
sequence and on the particle surface. It can be more efficient in decreasing the 
intrinsic reaction barriers. The method using active site-directed capture ligands could 
effectively capture the enzyme by modifying ligand on the particle support. There are 





 Protein trans-splicing is another very important 
method.  C-intein fragment can be covalently immobilized onto supporting particles, 
while N-intein is attached on C-terminus of the targeted enzyme. An active intein 





2.3.3.3 Purification of Enzymes with His-tag by MNPs 
 







modified surface is one of the most widely used and studied methods for enzyme 
purification. The advantages comparing with other methods are its high affinity 
towards the modified supports and high flexibility in various protein expression 
systems. Generally, after loading with his-tagged enzyme with other unwanted 
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proteins onto the particle system, the mixture is incubated for a certain time, and then 
the unwanted proteins were washed out, followed by eluting the target proteins with 
high concentration of imidazole. Ni loaded nitrilotriacetic acid (Ni-NTA) modified 
PtFe MNPs were used to bind histidine-tagged modified GFP. 
150
 The loading 
efficiency could reach to 10-12 μg protein/ mg bead. Ni/NiO core-shell nanoparticles 
were also applied to attach his-tag GFP from cell lysate with good performance.
151
 
This process is similar as affinity chromatography,
152
 but just on suspended 
nanoparticles.  
 
2.3.3.4 Immobilization of Enzymes with His-tag by MNPs 
 
It is recently reported to use MNPs to immobilize His-tagged enzyme for catalysis. 
Cu-IDA modified γ-Fe2O3 nanoparticles were used to immobilize his-tagged T4 DNA 
ligase.
69
 Fe3O4-silica-NiO was used to attach his-tagged epoxide hydrolase.
70
 
However, there are two problems. First, MNPs system developed for enzyme 
purification was not suitable for enzyme immobilization and catalysis, giving rise to 
significantly decreased activity and very poor recyclability. Second, enzymes were 
purified in advance before immobilization, to avoid the attachment of other enzymes 
and thus possible side reactions. It is often tedious, time-consuming, low-yielding and 
costly to purify a target enzyme from the cell free extract (CFE).  
 
2.3.4 Biodiesel Production from Grease using Nano-biocatalyst 
 
There is an increasing awareness to produce alternative sustainable liquid energy 
supply such as biodiesel and bio-ethanol, which could be directly used for engines, to 
ease the heavy dependency on petroleum based fuels.
153
 Biodiesel produced from 
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vegetable oils, animal fats, microalgal oils, waste products of vegetable oil refinery or 





2.3.4.1 Technology Challenge to Produce Biodiesel from Grease Trap 
Oil 
 
Among different sourcing materials for producing biodiesel, grease trap oil could be 
considered as one of the most important potential candidates. This is mainly because 
of the low price of grease trap oil as well as its abundance in urban areas. Besides, 
grease trap oil is forbidden to be used in food industry for the reason of public health. 
The implementation of the law can further enhance the usage of this waste for energy 
industry. Production of biodiesel from grease trap oil could be an important solution 
for utilizing the waste oil, as well as it will ease the high pressure of energy supply in 
central business district (CBD) in developed areas.  
 
The traditional methods for biodiesel production apply acid or base as catalysts to 
conduct esterification and transesterification of oil to form fatty acid alkyl esters 
(FAAE). The problem for using grease trap oil is its high free fatty acid concentration. 
Base catalysts (sodium hydroxide or potassium hydroxide) fail to fulfill this task due 
to the formation of soap, which will also decrease the overall yield by consuming the 
catalyst. The downstream process for purification and isolation of biodiesel will also 
be difficult. The downstream cost and related environmental issues to neutralize acid 
or base is a non-avoided problem in traditional process. The problem for acid catalyst 
is its low reaction rate. It is reported that the catalyst required a 0.5-1 mol % catalyst 
concentration in 50 hour to reach a rather high yield,
156
 while base catalyst could 
reach same level of catalysis in 30 min. 
157
 Under this circumstance, the use of a 
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2.3.4.2 Enzymatic Methods for Biodiesel Production 
 
Comparing other chemical catalysts, enzymatic methods for biodiesel production are 
favored when using waste oil containing high FFA as feedstock. A range of lipases 
and other esterases have been reported for enzymatic biodiesel synthesis.
159
 The 
enzyme could condense FFA with alcohol to form ester, when alcohol to water ratio 
is high. Among different enzymes, Candida antarctica lipase B (CALB) was widely 
researched. Besides, Candida rugosa (CRL),
160





 and Thermomyces lanuginosa (TLL)
157
 were also 
been used for this purpose. In order to facilitate the separation after reaction and 
decrease the cost, these enzymes were immobilized on different supporting materials 
before catalysis. Novozym 435 is CALB immobilized on mesoporous structured 
material, while Liposyme TL IM is TLL immobilized on beads. These two 
immobilized enzymes are wildly used in biodiesel production. It has been reported 
that Nozoym 435 is quite efficient in decreasing the FFA amount in esterification 
reaction, while Liposyme TL IM is good at transesterification to transform 
triglyceride to biodiesel. 
 
2.3.4.3 Immobilization of CALB  
 
CALB, a versatile enzyme for esterification, transesterification and total fat 
hydrolysis, has a size of 6.21 nm × 4.67 nm × 9.21 nm from its X-ray result,
163
 with 
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the isoeletric point (pI) at pH 6.0.
164
 Generally, CALB is attached on supporting 
materials to enhance the stability and to make recycle possible. 
 
Table 2-4 summarizes the condition for immobilization on different supporting 
materials. It could be noticed that the most popular protocols are physical adsorption 
via hydrophobic interaction and covalent binding via surface epoxy group. The 
specific loading of CALB is quite different based on different surface area available 
as well as nature of support. The condition is generally under room temperature for 
24 hours’ reaction with buffer solution at neutral pH. These conditions could be 
applied for design of experiments (DOE) in the following section.  
 
Parameters e.g. water content, way of addition, amount of alcohols, amount of 
enzyme, and reaction temperatures, are also very important in this reaction. These 
parameters should also be considered in future experimental design.  
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for hydrolysis of 
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33 % of Novozym 
435 for esterification 
of polyglycerol and 
lauric acid 
24 hour at 
20 °C 
 
2.4 Research Challenges in Nano-biocatalysis 
 
From above-mentioned analysis on the current research progress in the field of nano-
biocatalysis, the following three aspects could be addressed to improve the 
performance of current system. 
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First, a facile method for producing MNPs with high stability, good recyclability, 
designed function and well-controlled shape should be developed. It is very important 
to develop nanoparticle supports to demonstrate the concept for nano-biocatalysis 
within the scope of green oxidation, and to prove the advantages comparing either 
larger bead or non-magnetic particles with the same size. CPO could be a good choice 
to demonstrate this concept since recycle and reuse of CPO must be achieved to 
decrease the overall cost in pharmaceutical synthesis. Besides, the catalytic reaction 
requires hydrogen peroxide as a facilitating substrate, which is also a deactivation 
reagent for CPO. The enzymatic stability after immobilization could be easily proven 
by using the system containing hydrogen peroxide. In addition, the loading method of 
CPO should also be considered to be simple and effective in the nano-biocatalytic 
system. The detailed experimental design and results will be presented in Chapter 
Four. 
 
Second, as purification step is always tedious, it is important to demonstrate the 
possibility to use magnetic nanoparticle to achieve both purification and site-specific 
immobilization in one-pot. Based on the initial study using nano-biocatalysis, it will 
be a very interesting topic and a useful method to achieve multiple tasks with 
maintaining the activity of the loaded enzyme. Among different methodologies, the 
most efficient way is to use his-tagged enzyme interacting with Ni-NTA modified 
MNPs, because of its high specificity and less interference to the enzyme 
performance after adding the tag. Besides, the engineering and production of his-
tagged enzyme is a routine research work in genetic engineering, which will not be 
difficult to obtain. Chapter Five will show the detailed study and its results in particle 
synthesizing and one-pot interaction.  
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Third, with consideration of using magnetic nano-biocatlaysis in real industrial 
process, biodiesel production from grease trap oil should be a good approach to 
demonstrate this concept. The problem of high fatty acid concentration in the waste 
oil can be decreased by using enzymatic catalysis. The reactions involved are also 
quite simple and straight-forward. With the respect of industrial process, the catalyst 
should be active, stable and reliable. Immobilized nano-biocatalyst provides all these 
advantages. The design of the experiments is from the engineering point of view, to 
decrease the overall cost with obtaining the best catalytic performance. This will also 
demonstrate the use of nano-biocatalyst in non-aqueous system by optimizing the 
immobilization protocols among covalent binding, physical adsorption, and hybrid of 
these two methods. Chapter Six will exhibit the detailed consideration and 
comparison with the non-magnetic micro-sized beads.  
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3.1.1 Chemicals for Particle Synthesis and Characterization 
 
Ferric chloride hexahydrate (FeCl3·6H2O, 97 %), ferrous chloride tetrahydrate 
(FeCl2·4H2O, 99 %), potassium oleate (40 wt. % in H2O), ammonium persulfate 
((NH4)2S2O8, ≥ 98.0 %), ammonium hydroxide (~28 % NH3 in H2O), glycidyl 
methacrylate (97 %), ethylenediamine (NH2CH2CH2NH2, 99 %), glutaraldehyde 
solution (25 % in H2O), Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate ( ≥ 97.0 %), 
iminodiacetic acid (≥ 98 %), nickel chloride (NiCl2, 98 %), methyl methacrylate 
(99 %), tetraethyl orthosilicate (98 %), 3-aminopropyltrimethoxysilane (97 %),  citric 
acid anhydrous (≥ 99.5 %), poly(acrylic acid) (Mw ~1,800), diethylene glycol (≥ 
99 %), ferric chloride anhydrous (97 %), sodium thiosulfate (> 98 %), glycine (≥ 
98.5 %), ethylenediaminetetraacetic acid (≥ 99 %), styrene (≥ 99.5 %), and Schiff’s 
reagent for aldehydes were purchased from Sigma-Aldrich. Isopropanol (HPLC) and 
ethanol (HPLC) were purchased from Fisher. Sodium hydroxide pellets (≥ 99 %) 
were supplied by Merck. Deionized water was purified through Millipore Elix water 
purification systems. 
 
3.1.2 Commercialized Enzymes 
 
Chloroperoxidase from Caldariomyces fumago (≥ 3,000 units/mL), lipase from 
Candida antarctica (≥ 1.0 units/mg), and lipase B Candida antarctica recombinant 
from Aspergillus oryzae (~ 9 units/mg) were supplied by Sigma-Aldrich. Novozym 
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435 (10000 units/g) and Lipozyme TL IM (225 units/g) were purchased from 
Novozymes.  
 
3.1.3 Culture and Purification of Enzymes 
 
3.1.3.1 Chemicals for Culture and Purification of Enzymes 
 
D-Biotin (98 %), and potassium phosphate dibasic anhydrous (≥ 99 %) were supplied 
by Sigma-Aldrich.  Difco™ yeast nitrogen base w/o amino acid, Czapek-Dox broth, 
yeast extract, tryptone, and agar were supplied by BD. D-glucose anhydrous was 
purchased from 1
st
 Base. Potassium dihydrogen phosphate (99 %) was supplied by 
Merck. Zeocin™ was supplied by Invitrogen.  
 
3.1.3.2 Formula of Culture Media 
 
Table 3-1 Stock solutions for preparing culture media of Picha pastoris 
Solution Ingredients 
500x B 0.02 % D-Biotin 
10x YNB  134 g·L-1 Difco™ yeast nitrogen base w/o amino acid 
10x D (20 %) 220 g·L-1 D-Glucose monohydrate 
10x PPB (1 M PPB, pH 6.0) 30.13 g·L-1 K2HPO4.3 H2O, 118.13 g·L
-1 KH2PO4 
 
Table 3-2 Agar plates and liquid media of Picha pastoris 
Media Ingredients 
YPD (-agar) 10 g·L-1 yeast extract, 20 g·L-1 trypton, (15 g·L-1 agar), 900 mL 
dH2O, after autoclaving: 100 mL 10xD added 
BMD 1 % 50 mL 10x D, 200 mL 10x PPB, 100 mL 10x YNB, 2 mL 500x B, 
650 mL dH2O 
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BMM2 (1 %) 10 mL MeOH, 200 mL 10x PPB, 100 mL 10x YNB, 2 mL 500x B, 
690 mL dH2O 
BMM10 (5 %) 50 mL MeOH, 200 mL 10x PPB, 100 mL 10x YNB, 2 mL 500x B, 
650 mL dH2O 
 
3.1.4 Reagents for Protein Analysis 
 
Sodium dodecyl sulfate (98 %), and Bradford reagent for protein assay were 
purchased from Sigma-Aldrich. BCA protein assay reagent for detection of lipase was 
supplied by the Thermo Scientific Pierce. Ni-NTA gel was purchased from Qiagen. 
Tris(hydroxymetyl) aminomethane (≥ 99 %) was supplied by J.T. Baker. 30 % 
Acrylamide and bis-acrylamide solution was purchased from Bio-rad. N,N,N ,´N -´
tetramethylethylenediamine (ultrapure) was supplied by Invitrogen. 
 
3.1.5 Chemicals for Biocatalysis 
 
2-Chloro-5,5-dimethyl-1,3-cyclohexanedione (≥ 98.0 %), thioanisole (99 %), 
propiophenone (99 %),  butyrophenone (98 %), 4-nitrophenyl butyrate (≥ 98.0 %),  
hexadecane (99 %), 2-(4-chlorophenyl)oxirane (96 %), methyl phenyl sulfoxide 
(97 %), and trans-Stilbene oxide (98 %), (S,S)-(−)-hydrobenzoin (99 %) were 
purchased from Sigma-Aldrich. Potassium chloride (99.5 %) was supplied by QRëc. 
Hydrogen peroxide solution (30 wt.  % in H2O) was purchased from Analar. 
Methanol (HPLC), acetonitrile (HPLC), and ethyl acetate (HPLC) were supplied by 
Fisher. Potassium hydroxide (≥ 99 %), hexane (HPLC), and sodium phosphate 
dibasic dehydrate (99.5 %) were supplied by Merck. 1-(4-chlorophenyl)ethane-1,2-
diol (~ 98 %) were purchase from Spectra Group. 
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3.2 Synthetic Methods 
 
3.2.1 Synthesis of Iron Oxide Magnetic Nanocrystals/Nanoclusters  
 
3.2.1.1 Oleic Acid Stabilized MNPs (OA-MNPs) 
 
A solution of 0.01 mol ferric chloride hexahydrate and 0.005 mol ferrous chloride 
tetrahydrate in 100 mL of de-ionized (DI) water in a 3-neck round bottom flask was 
stirred by mechanical stirrer at 80 ºC with argon bubbling for 30 min. 0.01 mol of 
potassium oleate was added, and the mixture was stirred for another 30 min. 35 mL of 
4 % ammonium hydroxide was added to the mixture.
56
 The reaction system turned to 
black immediately. The reaction continued at 80 ºC under argon bubbling for 30 min. 
The black liquid was centrifuged at 16700 g for 10 min at 20 ºC to separate unreacted 
oleic acid from MNPs. The middle layer black liquid was named as OA-MNPs. 
 
3.2.1.2 HGMS Purified Oleic Acid Stabilized MNPs (OA-HGMS-MNPs) 
 
High gradient magnetic separator (HGMS) was used to further purify OA-MNPs and 
eliminate the free oleic acid in the system, as well as wash out ammonium in the 
sample. Frantz isodynamic model L-1 was connected with XFR 150-B DC power 
supply and operates at 150 V with 2.2 A. A steel wool packed column was used to 
conduct separation under electromagnetic field. Typically, 10 mL of OA-MNPs were 
loaded into the column, and then washed by 5 mL of DI water with magnet on. The 
trapped particles were eluted out by 10 mL of DI water with magnet off. The 
collected particles in eluates were named as OA-HGMS-MNPs. 
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3.2.1.3 Citric Acid Stabilized MNPs (CA-MNPs) 
 
A solution of 0.01 mol ferric chloride hexahydrate and 0.005 mol ferrous chloride 
tetrahydrate in 100 mL of de-ionized (DI) water in a 3-neck round bottom flask was 
stirred by mechanical stirrer at 80 ºC with argon bubbling for 30 min. Similar with 
synthesizing OA-MNPs, 0.01 mol of citric acid was added, and the mixture was 
stirred for another 30 min. 35 mL of 4 % ammonium hydroxide was added to the 
mixture. The reaction system turned to black immediately. The reaction continued at 
80 ºC under argon bubbling for 30 min. The black liquid was named as CA-MNPs. 
(The use of this particle will not be reported in this thesis, since the particle was 
difficult for further coating.) 
 
3.2.1.4 Poly(acrylic acid) Stabilized Magnetic Nanocluster (PAA-MNPs) 
 
Sodium hydroxide (50 mmol) was dissolved in diethylene glycol (20 mL) under 
argon environment. This alkaline solution was heated to 120 °C for 1 hour and kept at 
70 °C, and named as NaOH-DEG. Typically, a solution containing poly(acrylic acid)  
(4 mmol based on unit weight), ferric chloride anhydrous (0.4 mmol), and diethylene 
glycol (17 mL) were heated to 220 °C for 30 min by heating mental with vigorous 
mechanical stirring, with argon protection. A transparent yellowish solution was 
formed. Afterwards, prepared NaOH-DEG solution (1.75 mL) was rapidly injected 
into the abovementioned mixture. The mixture turned black in a few minutes. After 1 
hour of aging, the particles were collected and washed by water and ethanol for 
several times.
171,172
 This particle was named as PAA-MNPs. (The use of this particle 
will not be reported in this thesis, since the particle size was too big to be used.) 
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3.2.2 Synthesis of Core-shell Structured MNPs 
 
3.2.2.1 Poly (glycidyl methacrylate) Coated MNPs (PGMA-MNPs) 
 
0.025 g ammonium persulfate and 0.316 mL glycidyl methacrylate monomer were 
added into a mixture containing 5 mL OA-MNPs with 25 mL DI water. The reaction 
was continued for 1 hour to 24 hours at 80 ºC under magnetic stirring. The resultant 
mixture was centrifuged at 16700 g for 10 min and washed by DI water for several 
times. The particle was redispersed in 30 mL DI water. This solution was named as 
PGMA-MNPs. 
 
3.2.2.2 Poly (methyl methacrylate) Coated MNPs (PMMA-MNPs) 
 
The synthesis was quite similar as PGMA-MNPs. 0.025 g ammonium persulfate and 
0.316 mL methyl methacrylate monomer were added into a mixture containing 5 mL 
OA-MNPs with 25 mL DI water. The reaction was continued for 1 hour at 80 ºC 
under magnetic stirring. The resultant mixture was centrifuged at 16700 g for 10 min 
and washed by DI water for several times. The particle was redispersed in 30 mL DI 
water. This solution was named as PMMA-MNPs. 
 
3.2.2.3 Poly (styrene) Coated MNPs (PS-MNPs) 
 
The synthesis was quite similar as PMMA-MNPs. 0.025 g ammonium persulfate and 
0.316 mL styrene monomer were added into a mixture containing 5 mL OA-MNPs 
with 25 mL DI water. The reaction was continued for 1 hour at 80 ºC under magnetic 
stirring. The resultant mixture was centrifuged at 16700 g for 10 min and washed by 
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DI water for several times. The particle was redispersed in 30 mL DI water. This 
solution was named as PS-MNPs. 
 
3.2.2.4 Co-Poly (methyl methacrylate)-Poly (glycidyl methacrylate)  
Coated MNPs (PMMA-PGMA-MNPs) 
 
The synthesis was quite similar as PMMA-MNPs. Typically, 0.025 g ammonium 
persulfate, 0.1 mL methyl methacrylate, and 0.1 mL glycidyl methacrylate were 
added into a mixture containing 5 mL OA-MNPs with 25 mL DI water. The reaction 
was continued for 1 hour at 80 ºC under magnetic stirring. The resultant mixture was 
centrifuged at 16700 g for 10 min and washed by DI water for several times. The 
particle was redispersed in 30 mL DI water. This solution was named as PMMA-
PGMA-MNPs. 
 
3.2.2.5 Silica Coated Oleic Acid Stabilized MNPs (Silica-OA-MNPs) 
 
A solution containing 4 mL OA-MNPs and 16 mL ethanol or isopropanol was well 
mixed under 25 °C, with adding 0.1 mL to 1 mL ammonium hydroxide. 0.1 mL to 1 
mL tetraethyl orthosilicate was slowly added into this mixture. The solution was 
incubated for 3 hours to 24 hours to form a brown suspension. The obtained mixture 
was separated by using permanent magnet and washed by DI water and ethanol for 
several times. The particle was redispersed into 4 mL DI water and named as Silica-
OA-MNPs. (The use of this particle will not be reported in this thesis, since the 
synthetic method was not stable with different particle size produced in different 
batch) 
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3.2.2.6 Silica Coated Poly(acrylic acid) Stabilized MNPs (Silica-PAA-
MNPs) 
 
The synthesis is similar as Silica-OA-MNPs. A solution containing 4 mL PAA-MNPs 
and 16 mL ethanol or isopropanol was well mixed under 25 °C, with adding 0.1 mL 
to 1 mL ammonium hydroxide. 0.1 mL to 1 mL tetraethyl orthosilicate (TEOS) was 
then slowly added into this mixture. The solution was incubated for 3 hours to 24 
hours to form a brown suspension. The obtained mixture was separated by using 
permanent magnet and washed by DI water and ethanol for several times. The particle 
was redispersed into 4 mL DI water and named as Silica-PAA-MNPs. (The use of 
this particle will not be reported in this thesis, since the particle was too big and out of 
nano-range) 
 
3.2.3 Functionalization of MNPs 
 
3.2.3.1 Amino Group Functionalized MNPs (EDA- MNPs) 
 
A solution containing 30 mL PGMA-MNPs solution and 3 mL ethylenediamine were 
incubated at 80 ºC for 12 hours. Afterwards, the particles were centrifuged at 16700 g 
for 10 min and washed by DI water for several times. The particle was redisperesed 
into 30 mL DI water and was named as EDA-MNPs. 
 
3.2.3.2 Aldehyde Group Functionalized MNPs (GA- MNPs) 
 
30 mL of glutaraldehyde solution was heated to 80 °C and vigorously stirred. 30 mL 
EDA-MNPs solution was slowly added into the abovementioned solution to avoid 
any unwanted aggregation. This reaction mixture was incubated for 3 hours at 80 °C. 
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Afterwards, the particles were centrifuged at 12000 g for 10 min and washed by DI 
water for several times. The particle was redisperesed into 30 mL DI water and was 
named as GA-MNPs.  
 
3.2.3.3 Nitrilotriacetic Acid Functionalized MNPs (NTA-PGMA-MNPs) 
 
2 mL 0.1 M Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate solution at pH 8.0 was 
added into 20 mL PGMA-MNPs solutions. This mixture was incubated at 25 °C for 
12 hours. Afterwards, the particles were centrifuged at 12000 g for 10 min and 
washed by DI water for several times. The particle was redisperesed into 22 mL DI 
water and was named as NTA-PGMA-MNPs. (The use of this particle will not be 
reported in this thesis, since the particle was not well-functionalized) 
 
3.2.3.4 Nitrilotriacetic Acid Functionalized MNPs (NTA-EDA-PGMA-
MNPs) 
 
2 mL 0.1 M Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate solution at pH 8.0 was 
added into 20 mL EDA-MNPs solutions. 1 mL glutaraldehyde solution was added in 
to the system to start the reaction. This mixture was incubated at 25 °C for 12 hours.  
Afterwards, the particles were centrifuged at 12000 g for 10 min and washed by DI 
water for several times. The particle was redisperesed into 22 mL DI water and was 
named as NTA-PGMA-MNPs. (The use of this particle will not be reported in this 
thesis, since the particle was aggregated) 
 
3.2.3.5 Nitrilotriacetic Acid Functionalized MNPs (NTA-MNPs) 
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Similar as synthesizing NTA-PGMA-MNPs. 2 mL 0.1 M Nα,Nα-
Bis(carboxymethyl)-L-lysine hydrate solution at pH 8.0 was added into 20 mL GA-
PGMA-MNPs solutions. This mixture was incubated at 25 °C for 12 hours. 
Afterwards, the particles were centrifuged at 12000 g for 10 min and washed by DI 
water for several times. The particle was redisperesed into 22 mL DI water and was 
named as NTA-MNPs. 
 
3.2.3.6 Ni Functionalized MNPs (Ni-NTA-MNPs) 
 
1 mL of 1 M nickel chloride at pH 8.0 was added into 10 mL NTA-MNPs. The 
reaction mixture was incubated for 12 hours before collection. The particle could be 
magnetically separated by permanent magnet, and washed by DI water for several 
times.  
 
3.2.4 Preparation of His-tagged stEH1 
 
3.2.4.1 Culture Conditions of Pichia pastoris CBS 7435_MutS_PotHis  
 
Pichia pastoris CBS 7435_MutS_PotHis was cultivated on YPD agar plate with 100 
µg/mL zeocin as antibiotic for 48 hours at 28 °C.  The yeast cell was further 
inoculated into 250 mL baffled shaking flask containing 100 mL BMD 1 % medium. 
The main culture was started by inoculating an overnight culture to OD600 in 0.1 in a 
2 L baffled shaking flask, with 135 mL BMD 1 % and covered with linen for good air 
permission. After 60 hours, 15 mL BMM10 were added in. In 10 hours and 24 hours 
after BMM10 induction, 1.5 mL methanol was added in twice. The yeast cell was 
harvested 24 hours after the last induction by centrifuging at 5000 g at 4 °C for 30 
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min. The supernatant was removed and the pellets were stored at -80 °C for further 
use.  This methodology was developed by Prof. Glieder Anton’s research group. 
 
3.2.4.2 Cell Free Extract Containing His-tagged stEH1 
 
In order to get the cell free extract, yeast cell was redispersed in 0.1 M phosphate 
buffer at pH 8.0. The cell suspension was under 30 kpsi for two passes. The cell 
debris was removed by centrifuging at 5000 g at 4 °C for 30 min. The supernatant 
was named as cell free extract (CFE). 
 
3.2.4.3 Purification of stEH1 by Commercialized Column 
 
Purified enzyme was obtained by using the following purification methods. 4 mL 
CFE was loaded into column with 1 mL of Ni-NTA gel suspension, containing 300 
mM NaCl and 10 mM imidazole. This suspension was well-mixed and then incubated 
steadily in 4 °C for 1 hour for effective binding. Afterwards, 4 mL of 0.1 M 
phosphate buffer at pH 8.0 containing 25 mM imidazole was used to wash out the 
unbounded protein from the column. Finally, 4 mL of 0.1 M phosphate buffer at pH 
8.0 containing 250 mM imidazole was used to elute pure his-tagged epoxide 
hydrolase. In order to remove imidazole from the eluate, the collected eluate was 
further purified by using ultrafiltration film with 10 kDa cut by centrifuging at 6000 g 
at 4 °C for 2 hours. The protein pellets were redispersed in another 4 mL of 0.1 M 
phosphate buffer at pH 8.0. This solution was named as purified free stEH1 with 
concentration at 0.78 mg/mL. 
 
3.2.5 Immobilization of Enzymes on MNPs 
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3.2.5.1 Immobilization of CPO on EDA-MNPs 
 
62.5 mM glutaraldehyde was added into the mixture of 1.0 mL of 50 mM citric acid 
buffer (pH 4.75) containing 1.6 mg EDA-MNPs and 65 μg of CPO. The mixture was 
shaken at room temperature at 30 rpm on a rocking chair for 16 hours.  Afterwards, 
the immobilized CPO on MNPs was centrifuged at 5000 g, and separated by magnetic 
field to remove free CPO. The solid was treated with 1.0 M NaCl and then 50 mM 
citric acid buffer (pH 4.75) to wash away any physically bonded CPO. These MNPs 
(CPO-EDA-MNPs) were stored at 4 ºC for further application. 
 
3.2.5.2 Purification and Immobilization of His-tagged EH on Ni-NTA-
MNPs 
 
A solution containing 0.5 mg/mL protein, 2.0 mg/mL Ni-NTA-MNPs at pH 8.0, 0.1 
M phosphate buffer was incubated at 4 °C for 12 hours. Afterwards, the supernatant 
was separated from particles by using magnetic field. The protein concentration in the 
supernatant was analyzed by using Bradford reagent by comparing with BSA 
standard sample. The particle with magnetic property was further washed twice by 
using 0.1 M phosphate buffer at pH 8.0. This particle with immobilized enzyme was 
named as EH-Ni-NTA-MNPs. 25 mL of immobilization protocol was conducted 
under similar conditions as mentioned previously with same concentration of stEH1 
and MNPs.  
 
3.2.5.3 Verification of binding selectivity between Ni-NTA-MNPs and 
his-tagged EH 
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Several samples of EH-Ni-NTA-MNPs were incubated with different concentration 
of imidazole solution (0 mM - 250 mM) at 4 °C for 1 hour. The eluate was obtained 
afterwards by separating particles out from the system. CFE and supernatant during 
immobilization, together with the above-mentioned eluate were further analyzed by 
using SDS-PAGE. 
 
3.2.5.4 Immobilization of Lipase on MNPs 
 
Immobilization of lipase was accomplished by using 1 mL system containing 1 mg 
enzyme and 2.5 mg particles at different pH buffered by phosphate salt solution. The 
mixture was incubated at 4 °C, 12 hours, 30 rpm. For larger amount of the 
immobilization, the condition was similar, which contained 15 mg of enzyme in 20 
mL system. The immobilized bio-nanocatalyst was then collected by magnetic 
separation after mild centrifugation at 5000 rpm for 5 min.  These particles (lipase-
MNPs) were stored at 4 ºC for further application. 
 
3.3 Characteristic Methods 
 




Transmission electron microscope (TEM) was performed on JEOL: JEM-2010 
model. 20 µL liquid sample containing MNPs was dropped on copper grid with 200 
mesh carbon coating on a filter paper. Typically, the sample will be dried in room 
temperature for overnight. 
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3.3.1.2 FESEM 
 
Field emission scanning electron microscope (FESEM) was performed on JEOL: 
JSM-6700F model. 10 µL liquid sample containing MNPs was dropped on copper or 
carbon tape. Typically, the sample will be dried in room temperature for overnight. In 
addition, 5 nm platinum particles will be coated on particle surface to improve the 
conductivity.  
 
3.3.1.3 Dynamic Light Scattering (DLS) 
 
Zetasizer nano-ZS from Malvern was used to measure the volume size distribution 
and zeta-potential of particles in solution. The diluted liquid sample was injected into 





Zetasizer nano-ZS from Malvern was used to measure the volume size distribution 




Fourier transform infrared spectroscopy (FTIR) was performed on Bio-Rad 
Spectrometer of FTS 135. The sample was freeze-dried to powder before 
measurement. 2 mg of sample was well-mixed with 98 mg KBr before making a thin 
pellet under high pressure. The background pellet was only made by anhydrous KBr.  
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3.3.1.6 TGA 
 
The thermal stability of the nanoparticle was studied by thermogravimetric analysis 
(TGA). The samples were heated from room temperature to about 700 °C at a heating 
rate of 10 °C min−1 under a dry nitrogen atmosphere in a Du Pont Thermal Analyst 




Vibrating sample magnetometer (VSM) data were collected on two different 
equipments: Oxford Maglab and ADE magnetic EV-7. In Oxford Maglab, The 
freeze-dried sample was wrapped by a small piece of alumni foil before measurement, 
while in the case of ADE magnetic EV-7, samples were loaded on a plastic holder 
and sealed by using melting wax. Then the samples were fixed on the rod in the 
electromagnetic field.  The vibration distances were recorded by the equipment by 




Brunauer–Emmett–Teller (BET) data were performed on BET Analyzer: 
Quantachrome: NOVA 3000. The freeze-dried sample was used to conduct 
measurement. (The result of BET will not be reported in the thesis, since the error of 
the equipment was huge during analysis) 
 
3.3.1.9 Quantitative Assay of Epoxy Group 
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In order to further quantitatively characterized the amount the epoxy group on the 
particle surface, the reactive epoxide groups were determined by a procedure 






 group could be monitored and be neutralized by adding acid 
quantitatively. The procedures are as follows: certain quantities of epoxy-activated 
particles were magnetically separated and resuspended in 3 ~ 5 mL of DI water and 
transferred to pH titration vessel. The pH was adjusted to 7.0, and 3 ~ 5 mL of 2 M 
sodium thiosulphate will be added into the stirred solution. The pH was kept constant 
until the reaction was completed (around 30 min) by adding of 24.33 mM HCl. The 
amount of the epoxide groups presented in the solution could be calculated from the 
amount of HCl needed in order to maintain neutrality.  
 
3.3.2 Analytical Methods for Product Detection in Biocatalysis 
 
3.3.2.1 Oxidation Product of CPO 
 
Reverse phase HPLC was used to quantitatively analyze the product formation. Two 
different C18 columns were used, which is Agilent (4.0×125 mm, 5 μm), and Agilent 
Eclipse Plus (4.6×155 mm, 3.5 μm). The mobile phase consisted of acetonitrile and 
water with different ratio. For preparing samples for chiral HPLC, the aqueous 
solution was mixed with same amount of ethyl acetate, and the organic phase was 
separated, dried over MgSO4 and filtrated. The ee of product was determined by 
Chiral HPLC with OD-H column (250 × 4.6 mm, 5 μm, Daicel): mobile phase, 
hexane (90 % v/v) and iso-propanol (10 % v/v); flow rate at 1.0 mL/min; retention 
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time: 11.7 min for (R)-methyl phenyl sulfoxide, 15.8 min for (S)-methyl phenyl 
sulfoxide. 
 
3.3.2.2 Hydrolysis Product of EH 
 
Reverse phase HPLC was used to quantitatively analyze the product formation: C18 
column (Agilent Eclipse Plus, 4.6×155 mm, 3.5 μm); mobile phase consisted of 
acetonitrile (55% v/v) and water (45% v/v); flow rate of 1.0 mL/min; detection at 210 
nm; retention time: 2.06 min for 1-(4-chlorophenyl)ethane-1,2-diol, 5.50 min for 2-
(4-chlorophenyl)oxirane, 6.49 min for n-butyrophenone (internal standard). For 
preparing samples for chiral HPLC, the aqueous solution was mixed with same 
amount of ethyl acetate, and the organic phase was separated, dried over MgSO4 and 
filtrated. The ee of product was determined by Chiral HPLC with AS-H column 
(Daicel, 250 × 4.6 mm, 5 μm): mobile phase, hexane (90 % v/v) and iso-propanol (10 
% v/v); flow rate at 1.0 mL/min; detection at 210 nm; retention time: 6.00 min for 
(R)-2-(4-chlorophenyl)oxirane, 6.76 min for (S)-2-(4-chlorophenyl)oxirane, 10.83 
min for (S)-1-(4-chlorophenyl)ethane-1,2-diol, and 12.36 min for (R)-1-(4-
chlorophenyl)ethane-1,2-diol. 
 
3.3.2.3 GC and GC-MS 
 
The sample from the reaction mixture was analysed on an Agilent 7890 Series GC 
equipped with a HP-5 column (0.25 mm × 30 m) and a FID detector. 50 μL of the 
reaction mixture were taken at predetermined time intervals and analysed for methyl 
palmitate (C16:0), methyl stereate (C18:0), methyl oleate (C18:1), methyl linoleate 
(C18:2) and methyl linolenate (C18:3) using gas chromatography. The reaction 
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mixture was mixed for 1 minute with an equivalent volume of DI water and 
centrifuged at 15,000 rpm for 10 minutes. 5 μL of the top layer was then dissolved in 
995 μL of 2 mmol/L n-hexadecane (internal standard) in n-hexane. A solution of 4.25 
mg/mL of BD sample was obtained. Starting at 150 °C for 1 min and then heating to 
200 °C at 2 °C/min, holding at 200 °C for 2 min, followed by heating to 280 °C at 30 
°C/min. Identification of various methyl ester fatty acids as mentioned above was 
based on GLC-10 FAME Mix, methyl oleate and methyl linoleate standards. GC-MS 





Shimadzu UV-Vis 1700 spectrophotometer with time scan function, wavelength 
function, and adsorption function was used to detect the adsorption of protein samples 
as well as the product formation in protein assay. 
 




The activity of CPO could be analyzed by using monochlorodimedon (MCD) as 
substrate.
174
 The activity was defined by using the following equation. One unit will 
catalyze the conversion of 1.0 μmol of MCD to DCD per minute at pH 2.75 at 25 ºC 
in the presence of KCl and H2O2. 
 
Chapter 3 Materials and Methods                                                                                               61 | P a g e  
units /mg enzyme=
A278/min Test A278/min Test-
(12.04)(mg enzyme/ml Reaction Mix)  
 (Equation 3-1) 
12.2 = millimolar extinction coefficient of MCD at 278 nm, 1 cm cell 
0.16 = millimolar extinction coefficient of DCD at 278 nm, 1 cm cell 
 
 
3.3.3.2 Epoxide Hydrolase 
 
Hydroxylation of trans-stilbene oxide (TSO) to meso-hydrobenzoin (MHB) was used 
to test the activity of epoxide hydrolase as shown in Figure 3-1. Certain amount of 
cell was resuspended into 990 μL 50 mM pH 7.0 phosphate buffer. TSO was 
dissolved in ACN (10 mM stock solution). 10 µL of this TSO stock solution was 
added into the buffer system. The reaction was incubated at 30 ºC. 100 μL of sample 
was taken at 10 min, 60 min, and 180 min. 100 μL of acetonitrile was added into the 
taken solution and mixed, followed by centrifugation at 10000 rpm for 10 min. The 







TSO MHB  
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The activity of both the immobilized enzyme and free enzyme were analyzed by 
using p-nitrophenol-butyrate (pNPB) as substrate. UV detector was used to monitor 




3.3.4.1 Sulfoxidation of thioanisole with CPO-EDA-MNPs or free CPO 
 
490 μL of 50 mM citric acid buffer (pH 4.75) containing 50 mM thioanisole and the 
nano-biocatalyst (CPO-EDA-MNP) containing 30 μg CPO that was immobilized on 
the surface were mixed. 10 μL of 250 mM H2O2 was added every 10 min and the 
mixture was shaken at 30 rpm and room temperature. Samples were taken at 20 min, 
40 min, 60 min, 80 min and 100 min, and the supernatant was separated by 
centrifugation at 5000 g and then under magnetic field. For preparing samples for 
reverse phase HPLC, the solution was mixed with equal amount of acetonytrile 
containing 2 mM of propiophenone as internal standard.  
 
3.3.4.2 Hydroxylation of 2-(4-chlorophenyl)oxirane with stEH1-Ni-
NTA-MNPs or purified free EH in 1 mL scale 
 
stEH1-Ni-NTA-MNPs or purified free enzyme with 0.342 mg protein was added into 
a 990 µL of 0.1 M phosphate buffer at pH 8.0. This reaction was started by adding a 
10 µL acetonitrile solution containing 1.0 M 2-(4-chlorophenyl)oxirane. The reaction 
mixture was incubated at 30 °C for 2 hours. Several samples were taken along the 
reaction at different time intervals. The supernatant was separated by centrifugation at 
5000 g and then under magnetic field. For preparing samples for reverse phase 
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HPLC, the solution was mixed with equal amount of acetonitrile containing 2 mM of 
propiophenone as internal standard.  
 
3.3.4.3 Hydroxylation of 2-(4-chlorophenyl)oxirane with stEH1-Ni-
NTA-MNPs in 20 mL and preparation of (R)-2-(4-
chlorophenyl)oxirane 
 
stEH1-Ni-NTA-MNPs with 0.342 mg/mL protein was added into a 19.8 mL of 0.1 M 
phosphate buffer at pH 8.0. This reaction was started by adding a 200 µL acetonitrile 
solution containing 1.0 M 2-(4-chlorophenyl)oxirane. The reaction mixture was 
incubated at 30 °C for 1 hour. The conversion and ee of 2-(4-chlorophenyl)oxirane 
was analyzed at different time. The resulted solution containing 2-(4-
chlorophenyl)oxirane and 1-(4-chlorophenyl)ethane-1,2-diol was further extracted by 
hexane for three times (1:1 ratio). Hexane was evaporated by vacuum evaporator with 
bath temperature at 60 °C. The final purified product (R)-2-(4-chlorophenyl)oxirane 
had a yield of 33 % (theoretical maximum at 50 % for racemic resolution) and ee > 
99 %. 
 
3.3.4.4 Esterification by Using CALB-MNPs 
 
Different amount of freeze-dried CALB-MNPs was added into 5 g of grease trap oil. 
The reaction mixture was shaken to homogeneous before addition of proper amount 
of methanol (1:1; 1:3; 1:5) to start the esterification reaction. Samples were taken at 
30 min, 1 hour, 2 hours, 3 hours, 6 hours and 24 hours, to analyze the acid value by 
using standard KOH solution (20 mM), or analyze the ester formation by using GC or 
GC-MS. 
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3.3.4.5 Transesterification by Using CALB-MNPs 
 
Different amount of freeze-dried CALB-MNPs was added into 5 g of grease trap oil. 
The reaction mixture was shaken to homogeneous before addition of proper amount 
of methanol (1:1; 1:3; 1:5) to start the transesterification reaction. Samples were taken 
at 3 hours, 6 hours and 24 hours, to analyze transesterification efficiency by using GC 
or GC-MS. 
 




To 490 μL of 50 mM citric acid buffer (pH 4.75) containing 5 mM thioanisole and 
the nano-biocatalyst (CPO-EDA-MNP) containing 30 μg CPO that was immobilized 
on the surface was added 10 μL of 250 mM H2O2. The reaction was performed at 30 
rpm and room temperature for 10 min, and the supernatant was separated from the 
catalyst by 5000 g and magnetic field for HPLC analysis. The catalyst was added to 
490 μL of 50 mM citric acid buffer (pH = 4.75) containing 5 mM thioanisole, and 10 




990 μL of 0.1 M phosphate buffer at pH 8.0 was added into EH-Ni-NTA-MNPs 
containing 0.342 mg protein. This reaction was started by adding a 10 μL acetonitrile 
solution containing 1.0 M 2-(4-chlorophenyl)oxirane. The reaction mixture was 
incubated at 30 °C for 40 min in each cycle. The particles were separated by magnetic 
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control. The supernatant was analyzed by HPLC. Afterwards, fresh buffer and 




0.01 g of Freeze-dried CALB-MNPs was added into 1 g of grease trap oil. The 
reaction mixture was shaken to homogeneous before addition of proper amount of 
methanol to start the esterification reaction. After three hours of reaction, CALB-
MNPs were magnetically separated and washed by 1 mL of hexane to remove the 
glycerol attached on the surface. Fresh grease trap oil at 1 g was added into these 
washed CALB-MNPs to start a new cycle. The oil sample was used for titration. 
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4 RECYCLABLE NANO-BIOCATALYST FOR 
ENANTIOSELECTIVE SULFOXIDATION: FACILE 
FABRICATION AND HIGH PERFORMANCE OF 
CHLOROPEROXIDASE-COATED MNPS WITH IRON OXIDE 




MNPs (MNPs) have received increasing attention in bio-related research due to 
several distinct properties such as high surface area to volume ratio, special magnetic 
behavior, and high dispersibility in various solvents.
6,13
 An important application for 
MNPs is biocatalysis, which has profound impact on green and selective chemical 
syntheses. Enzyme-coated nano-sized magnetic particles used as highly stable nano-
biocatalyst could be simply recycled under external magnetic field. Compared with 
enzymes immobilized on micrometric supports, nano-biocatalyst could achieve a 
much higher enzyme loading capacity, and it could significantly enhanced mass 
transfer efficiency. An attractive approach for fabricating nano-biocatalyst is to 
immobilize enzyme on iron oxide MNPs, which are cheap and biocompatible. Several 




 and alcohol dehydrogenase
176
 
have been thus far immobilized on such MNPs.  
 
The major problems in the fabrication of nano-biocatalysts at current stage are the 
unsatisfactory catalyst stability during operation and recycling process and the 
dramatically reduced activity in comparison with free enzyme. There are two aspects 
for the unsatisfactory stability. First, the stability of the catalyst should be maintained 
after immobilization. However, entrapment
81
 and physical adsorption
82
 of enzyme on 
iron oxide MNPs suffered from the leakage of enzyme activity during reaction and 
recycling. Second, the particle itself should be stable enough during the process. 
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However, enzymes covalently immobilized on the surface of iron oxide MNPs 
showed unsatisfactory stability under harsh conditions and led to particle 
aggregation.
3,175
 The use of silica encapsulated iron oxide MNPs for covalent enzyme 
attachment
79,80
 allowed to increase the catalyst stability to some extent, but the 
obtained stability was not sufficient for efficient recycling and reuse of the catalyst, 
which may be due to the oxidation of magnetic core with a rather porous silica 
coating. Furthermore, the silica shell may contain pores under alkaline condition, and 
the particle size distribution is difficult to control with complicated and low-yielding 
synthetic method.
13
 Here in Chapter Four, we report a new and simple method for 
fabricating active and recyclable nano-biocatalyst by covalently immobilizing 
enzyme on stable MNPs with core containing multiple iron oxide MNPs and thick 
polymer shell. Meanwhile, there is an increasing demand to develop efficient 
biocatalysts for asymmetric and green oxidations to prepare enantiopure fine 
chemicals. In this work, we focus on developing enantioselective oxidative nano-
biocatalyst derived from chloroperoxidase (CPO). 
 
4.2  Methodology 
 
4.2.1 Overall Concept 
 
MNPs (MNPs) with 30 nm diameter core comprising several iron oxide crystals, 
poly(glycidyl methacrylate) (PGMA) shell with thickness of 30 nm, and surface 
coated with CPO were facilely fabricated. The covalently bound CPO did not change 
the original conformation of the active site and showed the same catalytic activity and 
enantioselectivity as free CPO for the sulfoxidation of thioanisole to produce (R)-
methyl phenyl sulfoxide in > 99 % ee. The thick PGMA shell significantly increased 
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the stability of the nano-biocatalyst: no loss of the apparent activity was observed for 
the sulfoxidation for 12 cycles. Thus, the nano-biocatalyst fabricated here showed the 
best performance among nano-sized biocatalyst particles regarding both the retaining 
of free enzyme activity and the recycling of catalyst. This is also the first example of 
nano-biocatalyst for asymmetric oxidation, and the concept could be generally 
applicable for fabricating active and recyclable nano-biocatalysts. Figure 4-1 
demonstrates the overall concept for synthesis and application.  
 
 
Figure 4-1 Overall concept of covalent immobilization of chloroperoxidase on functionalized MNPs 
 
4.2.2 Experimental Design 
 
Experimental design for achieving nano-biocatalyst is composed of two parts, which 
are synthesis and characterization of nano-biocatalyst.  
 
4.2.2.1 Flowchart of Synthesis 
 
Figure 4-2 presents the flowchart for synthetic procedure of magnetic nano-
biocatalyst with CPO.  Iron oxide particles (OA-MNPs) were prepared by co-
precipitation method with oleic acid as the stabilizer. Glycidyl methacrylate (GMA) 
containing epoxy functional group was then used as a monomer for in situ 
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polymerization in the presence of OA-MNPs, giving new nano-particles (GMA-
MNPs). Reaction of GMA-MNPs with ethylenediamine gave the corresponding 
particles with amino groups (EDA-MNPs). An immobilization protocol was 
demonstrated by using CPO as the target enzyme. Nano-biocatalyst (CPO-EDA-




Figure 4-2 Flowchart of synthetic procedure of magnetic nano-biocatalyst (CPO-EDA-MNPs) 
 
4.2.2.2 Flowchart of Particle Characterization 
 
Figure 4-3 shows the flowchart for characterization of magnetic nano-biocatalyst 
(CPO-EDA-MNPs) and other nanoparticles during synthesis. Three major properties 
of nanoparticle (size, function and magnetic behavior) were characterized by using 
various facilities. 
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Figure 4-3 Flowchart of characterization of nano-biocatalyst 
 
4.2.2.3 Performance of Nano-biocatalyst 
 
The catalytic performances of magnetic nano-biocatalyst (CPO-EDA-MNPs) were 
identified by using enzymatic reaction, monitoring the formation of product by HPLC 
or UV spectrophotometer. In addition, kinetic studies were conducted to evaluate the 
influence on enzyme functional structure after immobilization. The nano-biocatalyst 
was also reused and recycled to perform catalytic reactions to demonstrate the 
reusability. 
 
4.3 Results and Discussion 
 
4.3.1 Particle Characteristics 
 
MNPs and nano-biocatalyst were characterized by using different equipment to verify 
the concept of synthesis.  
 
4.3.1.1 Size and Shape 
 
Size TEM FESEM DLS 
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OA-MNPs were prepared in 89 % yield by co-precipitation method with oleic acid as 
a stabilizer. TEM image showed that the mean size of OA-MNPs is 15 nm in 
diameter (Figure 4-4a), which also indicates that the particles are super-paramagnetic, 
as this size of the nanoparticle can only contain single domain of iron oxide. The 
yield for synthesizing GMA-MNPs was 61 %, which had a core-shell structure. 
GMA-MNP had a mean size of about 90 nm, with a core in a diameter of 30 nm 
containing several OA-MNPs and a poly (GMA) shell in thickness at 30 nm (Figure 
4-4b). This structure could effectively prevent the iron oxide core from leaching and 
further oxidation under harsh conditions. The distribution curve of GMA-MNPs is 
given in Figure 4-5, which showed that GMA-MNP was monodisperse with 
polydispersity index (PDI) at only 0.006.  
 
For obtaining better activity of the immobilized enzyme, ethylenediamine was used to 
prolong the bridge between the enzyme and MNPs. Reaction of GMA-MNPs with 
ethylenediamine gave the corresponding particles with amino groups (EDA-MNPs) 
in > 99 % yield. No dramatic shape or morphology change was observed during the 
modification due to the dense polymer coating, and the resulting EDA-MNPs 
maintained spherical core-shell structures with a diameter of about 90 nm (Figure 
4-4c).  
 
CPO was immobilized on EDA-MNPs by covalent binding using glutaraldehyde as a 
linker. The morphology and size of CPO-EDA-MNPs did not change significantly 
after immobilization (Figure 4-4d). 
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Figure 4-4 (a) TEM image of OA-MNPs. (b) TEM image of GMA-MNPs. (c) FESEM image of EDA-




Figure 4-5 DLS analysis of core/shell structured GMA-MNPs in aqueous buffer. 
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4.3.1.2 Function and Stability 
 
The FTIR result of GMA-MNPs in solid state is shown in Figure 4-6, and the coating 
of ploy (GMA) on OA-MNPs were confirmed by the observed peaks for GMA. This 
result verified the successful coating of iron oxide seeds with polymer shell. It also 
verified the existence of iron oxide inside the nanoparticles. 
 
 
Figure 4-6  FTIR of GMA-MNPs in solid state with KBr matrix 
 
The epoxide group on GMA-MNPs could react with sodium thiosulphate and 
generate OH
-
 group shown in Figure 4-7. The OH
-
 group produced could be 
quantitatively monitored and neutralized by adding standard acid to maintain the pH 
at 7.0. The amount of acid could be transferred to the amount of epoxy group in the 
sample. From this titration assay, the amount of epoxy group on GMA-MNPs was 
890 μmol/g, which was amount two times than commercialized epoxy carrier 























Figure 4-7 Quantification reaction of epoxy group 
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TGA analysis was conducted in order to get the composition of MNPs. Figure 4-8 
shows the TGA result of OA-MNPs. From the MSDS of oleic acid, it should 
decompose at 80-100 °C. We found that from 100 °C to 340 °C, there was a sharp 
weight lost, which was 69 % of the starting weight. This indicated the lost of 
decomposition of oleic acid. After 340 °C, the weight loss became slower. We could 
conclude that around 70 % weight was oleic acid in these OA-MNPs, and the other 
30 % was iron oxide. 
 
Figure 4-8 TGA analysis of OA-MNPs 
 
We also conducted TGA for the GMA-MNPs synthesized by suspension 
polymerization. The boiling point (bp) of the GMA monomer is 189 °C, after 
polymerization, the bp should be increased during the cross-linking. From , we found 
that from the initial temperature to 645 °C, 93 % of the total weight was lost of the 
GMA-MNPs. The left 7 % should be the iron oxide. The GMA-MNPs was obtained 
by coating the OA-MNPs with GMA polymer, and all the OA-MNPs were 
encapsulated. So the ratio of iron oxide and oleic acid should maintain. Based on the 
previous results, we could conclude that 16 % of the weight loss is from oleic acid 
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Figure 4-9 TGA analysis of GMA-MNPs 
 























Figure 4-10 Zeta-potential of GMA-MNPs in aqueous buffer at different pH 
 
The zeta-potential of OA-MNPs was -39.8mV at pH 10, this means that OA-MNPs 
was quite stable under this condition. The pI of OA-MNPs was around pH 7, and this 

























TGA analysis of GMA-MNPs 
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The zeta-potential profile of GMA-MNPs was shown in Figure 4-10. It could be 
observed that GMA-MNPs were also quite stable in high pH. It would not aggregate 
easily. In experiment, the GMA-MNPs could be stored for weeks without any 
permanent aggregation or decomposed shell. The zeta-potential profile of EDA-
MNPs was presented in Figure 4-11. EDA-MNPs had pI around pH 4.0. Above pH 
4.0, there particles carried negative charge, while they carried positive charge below 
pH 4.0.  
 
 
Figure 4-11 Zeta-potential of EDA-MNPs in aqueous buffer at different pH 
 
4.3.1.3 Magnetic Property 
 
The magnetic property of OA-MNPs and GMA-MNPs were shown in Figure 4-12. 
OA-MNPs showed strong magnetic properties as magnetic fluids, which could be 
easily attracted by using external magnetic field within a short time (< 1 second). 
After coating with poly (GMA), the response of the particle under magnetic field 
decreased. This is due to the increased weight and size of the nanoparticle by 
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demonstrated in Figure 4-13 (a)-(b). The nano-biocatalyst was easily and quickly 
separated under an external magnetic field.  
 
VSM in Figure 4-13c showed that CPO-EDA-MNPs exhibited super-paramagnetic 
behavior at 298 K with a saturated magnetization value of 1.74 emu/g particles. For 




Figure 4-12 Magnetic behavior of (a) OA-MNPs; (b) GMA-MNPs 
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Figure 4-13 (a) CPO-EDA-MNPs in buffer; (b) Separation of CPO-EDA-MNPs by magnet after 2 min; 
(c) VSM of CPO-EDA-MNPs. 
 






























Figure 4-14 VSM of OA-MNPs 
 
4.3.2 Loading of Enzyme  
 
The property of CPO was studied in terms of its amino acid sequences. The loading 
of enzyme on magnetic nano-support was considered both theoretically and 
experimentally. 
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4.3.2.1 Study of CPO 
 
The nature of enzyme is a key factor when selecting the immobilization method. The 
location of the active site and the key amino acid residues related to the 
immobilization protocol may hugely vary for different enzymes, which means that it 
could not be guaranteed that one successful immobilization system to certain 
enzymes could always be suited for other enzymes. The three-dimensional structure 
of the enzyme, the enzyme susceptivity to ambient conditions, the character of the 
catalytic reaction should always be considered.  
 
In our study, CPO is quite sensitive to high pH. It will lose its full activity within a 
few minutes above pH 7. This scenario should be considered and immobilization at 
high pH should also be avoided. The three-dimensional structure of CPO should also 
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Figure 4-15 3D structure of chloroperoxidase from X-ray Diffraction (RCSB Protein Data Bank, 1CPO 
provided by Sundaramoorthy, M) (a) Backbone (b) Surface estimation by Varshney method with probe 
radius 1.5 
 
After analyzing the amino acid structure, it was found out that CPO contains five 
lysine groups, which are Lys 113, Lys 116, Lys 146, Lys 178, and Lys 212 (RCSB 
Protein Data Bank). Among them, the ε-amino groups of Lys 113, 146 and Lys 212 
are located on the protein surface and on the opposite side of the substrate access to 
the active site - heme group, while the ε-amino group of Lys 116 and Lys 178 are not 
on the protein surface (Figure 4-15). So the surface lysine will be a perfect choice for 
covalent immobilization. 
 
In order to fabricate a highly stable catalytic system containing enzyme and MNPs, 
several abovementioned factors should be considered during the experimental design. 
It is difficult to judge if an enzyme is suitable for a specific immobilization protocol 
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zone, location of active site, and amount of lysine/cysteine/histidine. Proper design of 
the immobilization system with tailored attaching protocol should always be the key 
of this question.  
 
4.3.2.2 Theoretical Calculation 
 
A theoretical calculation was made for estimating the total number of enzyme on a 
single particle after immobilization. From TEM results of GMA-MNPs, we could 
hypothesize that the core-shell structured particle possesses a core size at 30 nm and 
the total size is 100 nm. From X-ray results in literature, the real size of CPO is 
5.3 × 5.5 × 3.1 nm.
177
 In this model, enzyme molecule is considered as spherical size 
with a diameter at 6 nm, which is perfectly packed on the particle surface with a 
monolayer distribution. The footprint of each enzyme is supposed as rectangular 








 (Equation 4-1)        
)(
3


























 (Equation 4-4) 
 
Several important parameters are calculated and estimated from the model, including 
the specific surface area, total enzyme number on single MNPs, weight of single 
MNPs, and specific Enzyme loading amount. Equation 4-1, 2, 3 and 4 show the 
formula of these parameters. 
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In order to get specific number of those parameters in the model, simple estimation 
was made. ρc = 5.18 g/cm
3
 (density of Fe3O4), while ρs = 1.14 g/cm
3
 (density of poly 
(GMA)). The Mw of CPO is around 50 kDa. The length of linker is estimated as 2 nm. 
After simple calculation, the specific surface area is 49 m
2
 / g, which is similar with 
reported value. Total CPO number on single MNPs is around 890. The weight of 
single MNPs is 6.54 * 10
-16
 g. Finally, the maximum specific enzyme loading amount 
is 133 mg CPO / g MNPs, which is the ideal case when considering spatial hindrance.  
 
 
Figure 4-16 Model of immobilization of enzymes on MNPs 
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In addition, when changing the size of iron oxide core, arm length, and shell thickness 
respectively, the loading amount of enzyme may also change. The relationships were 
plotted in Figure  4-17, 18, 19. 
 
 
Figure 4-17 CPO loading capacity when changing the size of iron oxide core of nanoparticle (fixed shell 
thickness at 35nm, arm length at 2nm) 
  
Figure 4-18 CPO loading capacity when changing shell thickness of nanoparticle (fixed core size at 








































Shell thickness (nm) 
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Figure 4-19 CPO loading capacity when changing arm length of nanoparticle (fixed shell thickness at 
35nm, core size at 15nm) 
 
Decreasing core size could increase specific enzyme loading amount. However, the 
magnetic response of the system could be decreased as well. There should be an 
optimized shell thickness. In the case r = 15nm and l = 2nm, the optimized shell 
thickness is 10 to 20 nm. When particle size is fixed, the increase of arm length could 
increase in immobilization amount and the flexibility of immobilized enzyme. 
 
4.3.2.3 Experimental Results 
 
A specific loading of 16.1 mg CPO/g MNPs was achieved for the nano-biocatalyst 
(CPO-EDA-MNPs) at optimized ratios of those reactants. This value is five times 
higher than the reported data using micrometric support via similar covalent 
binding.
140
 Based on the composition and size of the MNPs as described above, about 
126 CPO molecules are bounded to one EDA-MNP using the experimental data. This 




















Arm length (nm) 
Chapter 4 Recyclable Nano-biocatalyst with Chloroperoxidase for Sulfoxidation                   85 | P a g e  





4.3.3 Activity of Nano-biocatalyst 
 
Asymmetric sulfoxidation of thioanisole to (R)-methyl phenyl sulfoxide was chosen 
as the target reaction to investigate the catalysis and the recycling of CPO-EDA-
MNPs. The profiles of the sulfoxidation of 50 mM substrate with 50 mM H2O2 
catalyzed by the nano-biocatalyst and free CPO, respectively, are shown in Figure 
4-20. In both cases, the product concentration increased linearly within 100 min, and 
no difference in catalytic performance was observed. The total turnover number of 
the nano-biocatalyst reached 25·10
3
, which was also close to the reported data for free 
CPO in aqueous buffer.
136,178
 Moreover, the product ee was >99 % (R) determined by 
chiral HPLC analysis (Figure 4-21). These results suggested that no change in 
enzyme activity and enantioselectivity after covalent immobilization.  
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free CPO
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Figure 4-22 Kinetic study of immobilized and free CPO 
immo = 0.408x + 15.61 
R² = 0.943 
free= 0.145x + 5.230 
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In addition, the Km of EDA-MNPs-CPO for monochlorodimedon was determined to 
be 26.1 μM, similar to the Km of 27.7 μM for free CPO (Figure 4-22). This indicated 
again that there was no significant conformational change of the enzyme active site 
after immobilization.  
 
4.3.4 Reuse and Recyclability of Nano-biocatalyst 
 
Recycling of the nano-biocatalyst was conducted for the sulfoxidation of 5 mM 
substrate with 5 mM H2O2 for 10 min. After each cycle, CPO-EDA-MNPs were 
magnetically separated and added to the new reaction medium containing substrate 
and H2O2. The separation of the particles was easy and high yielding. Figure 4-23 
showed the concentration of enantiopure (R)-sulfoxide produced in each cycle. After 
12 cycles, the nano-biocatalyst was still fully active, thus being much better than CPO 





Figure 4-23 Recycling and reuse of the nano-biocatalyst for the sulfoxidation 
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In conclusion, a facile method for preparing MNPs comprising iron oxide core, 
polymer shell, and enzyme-coated surface as a high performance nano-biocatalyst 
was designed and developed.  
 
The synthetic method for obtaining magnetic iron oxide seeds was quite simple with 
high yield. Co-precipitation of two iron salts with protection of a kink structured 
surfactant gave resulted in high-performance iron oxide crystal. The following 
coating technique developed based on in situ polymerization is also quite successful 
in terms of controlling the size and shell thickness. It also introduced enough epoxy 
groups on the surface of the MNPs for further modification.  
 
The magnetic nanoparticle showed good stability with maintaining the size and shape 
during further modification to bear with amino functional group for further 
application. Considering the magnetic response, the core of the nanoparticle and the 
core-shell structured nanoparticle presented good magnetic properties and can be 
controlled or separated by using external magnetic field. The physical property of the 
particle was characterized by using different methods, which verified the overall size 
(90 nm), and its morphology with a multiple core–shell structure.  
 
CPO was covalently bound on chemically modified magnetic nanoparticle with a 
long and flexible bridge, which provided theoretical base to achieve good enzymatic 
activity after loading. The experimental data showed that immobilized CPO had the 
same sulfoxidation activity and enantioselectivity as the free CPO. This can also be 
attributed to the location of three surface lysine of CPO, where they are on the 
opposite site of the enzyme active center. The interference of CPO activity after 
immobilization was minimized.  
Chapter 4 Recyclable Nano-biocatalyst with Chloroperoxidase for Sulfoxidation                   89 | P a g e  
Besides, the thick polymer shell significantly increased the stability of the nano-
biocatalyst, giving no loss of activity after recycling for 11 times. These results are 
much better than those achieved with CPO on other solid supports, and represent the 
best performance on activity retaining as well as catalyst recycling among nano-
biocatalysts known thus far. While it is the first example of a nano-biocatalyst for 
asymmetric oxidation, the new concept could be generally applicable for fabricating 
active and recyclable nano-biocatalysts.  
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5 FACILE FABRICATION OF RECYCLABLE AND ACTIVE 
NANOBIOCATALYST: PURIFICATION AND 
IMMOBILIZATION OF ENZYME IN ONE POT WITH NI-NTA 




In recent decades, enzymes are widely used in chemical and pharmaceutical industry 
to synthesize useful compounds with high chemo-, regio- and stereo-selectivities.
3,182
 
For facilitating enzyme recycling, enhancing enzyme stability and simplifying 
separation process, enzyme is preferably immobilized for biotransformation in 
vitro.
183
 With the recent development of nanotechnology, iron oxide MNPs (MNPs) 
have received increasing attention as supporting materials for enzyme immobilization 
with several distinctive features: high enzyme loading capacity due to the high 
specific surface areas to volume ratio, efficient catalysis with reduced mass transfer 
limitation due to the good dispersibility in solvents, easy catalyst separation under 
magnetic field due to the good magnetic properties, and low cost and easy synthesis 




In principle, enzyme could be covalently or non-covalently attached on MNPs to 
fabricate magnetic nano-biocatalyst.
75,80-82,90
 Although covalent attachment could 
have a steady performance during catalysis, it is difficult to achieve the free enzyme 
activity after immobilization because of the potential damage of enzyme active center 
by covalent binding.
75
 For non-covalent attachment, protocols based on absorption or 
entrapment suffer from enzyme leakage during recycling due to the weak binding 
forces.
81,82
 Alternatively, affinity immobilization is a promising methodology, since it 
could retain enzyme conformation and activity and minimize enzyme loss due to a 
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small dissociation constant.
70,184
 Currently, his-tagged enzyme can be easily 
engineered and produced, and it can also be purified by traditional affinity 
chromatography
152,185-187





Nevertheless, affinity immobilization of his-tagged enzyme on MNPs for efficient 
biotransformation has been thus far less successful.
187
 MNPs systems developed for 
enzyme purification were not applicable for catalysis, giving rise to significantly 
decreased activity and very poor recyclability.
69
 Therefore, it is a significant 
challenge and of great importance to develop appropriate functionalized MNPs for 
affinity enzyme immobilization to prepare active and recyclable nano-biocatalyst.  
 
In all above-mentioned immobilization protocols, enzymes were purified in advance 
to avoid the attachment of other enzymes and thus possible side reactions. It is often 
tedious, time-consuming, low-yielding and costly to purify a target enzyme from the 
cell free extract (CFE). For instance, to purify a his-tagged enzyme, the enzyme is 
attached to the materials via affinity, separated, and eluted with high concentration of 
imidazole; to recover the activity, imidazole has to be removed, and enzyme needs to 
be concentrated for further application. Thus, immobilization protocol based on pre-
purification of enzyme is discrete, complicated, and costly. Here in Chapter Five, we 
report a novel concept for facile fabrication of recyclable and active nano-biocatalyst 
via purification and immobilization of a his-tagged enzyme in one-pot by using stable 
core-shell structured iron oxide MNPs containing Ni-NTA groups on the surface. 
 
5.2  Methodology 
 
5.2.1 Overall Concept 
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The overall concept of one-pot purification and immobilization was demonstrated in 
Figure 5-1. His-tagged epoxide hydrolase were loaded on Ni-NTA functionalized 
magnetic nanoparticle via affinity binding force from cell free extract. This nano-
biocatalyst was further reused several times for conducting useful biotransformation 
to produce enantiopure product.   
 
Figure 5-1 Overall concept of using nano-biocatalyst with immobilized epoxide hydrolase 
 
5.2.2 Experimental Design 
 
5.2.2.1 Flowchart of Particle Synthesis 
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Figure 5-2 Synthetic scheme of stEH1-Ni-NTA-MNPs 
 
The synthetic route of the MNPs containing Ni-NTA surface function (Ni-NTA-
MNPs) is shown in Figure 5-2. First, iron oxide nanoparticle coated with oleic acid 
(OA-MNPs) were synthesized by a co-precipitation method.
90
 Afterwards, controlled 
polymerization of glycidyl methacrylate (GMA) in the presence of OA-MNPs 
afforded the synthesis of PGMA-MNPs with surface epoxy function. Further reaction 
with ethylenediamine gave the corresponding MNPs with amino group (EDA-MNPs), 
and the aldehyde group was introduced by subsequent reaction with glutaraldehyde to 
give GA-MNPs. An amine-containing NTA derivative was reacted with the aldehyde 
group of GA-MNPs to form NTA-MNPs. Finally, Ni
2+
 was loaded on the chelating 
NTA arms to produce Ni-NTA-MNPs.
 
A cell-free extract (CFE) of Pichia pastoris 
containing his-tagged Solanum tuberosum epoxide hydrolase (stEH1) 
188 
and other 
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enzymes was incubated with Ni-NTA-MNPs to achieve one-pot immobilization and 
nano-biocatalyst stEH1-Ni-NTA-MNPs. 
 
5.2.2.2 Flowchart of Particle Characterization 
 
Figure 5-3 shows the flowchart for characterization of magnetic nano-biocatalyst 
(stEH1-Ni-NTA-MNPs) and other nanoparticles during synthesis. Four major 
properties of nanoparticle (size, function, magnetic behavior and protein loading 
ability) were characterized by using various equipments. 
 
 
Figure 5-3 Flowchart of characterization of nano-biocatalyst stEH1-Ni-NTA-MNPs 
 
5.2.2.3 Performance of Nano-biocatalyst 
 
The catalytic performances of magnetic nano-biocatalyst (stEH1-Ni-NTA-MNPs) 
were identified by using enzymatic reaction, monitoring the formation of product, 
decreasing of substrate, as well as the increase of enantipurity of substrate.  The nano-
biocatalyst was also reused and recycled to perform catalytic reactions. 
Size TEM FESEM DLS 
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5.3 Results and Discussion 
 
5.3.1 Particle Characteristics 
 
MNPs and nano-biocatalyst were characterized by using different equipment to verify 
the concept of synthesis.  
 
5.3.1.1 Size and Shape 
 
Analyzed by DLS, all these MNPs are monodisperse with a rather narrow size 










Figure 5-4 Size distribution (by number) of (a) OA-MNPs, (b) PGMA-MNPs, (c) EDA-MNPs, (d) GA-
MNPs 
 
Figure 5-4 shows the result from DLS. The hydrodynamic size of OA-MNPs is 24.2 ± 
9.7 nm. After coating with GMA, the size increases to 90.2 ± 22.5 nm. The size of 
EDA-MNPs is 105.5 ± 26.7 nm, while the size of GA-MNPs is 114.2 ± 25.5 nm. By 
functionalization of the MNPs with different groups, the hydrodynamic size increases 
not much, which indicates successful attachment of those functions.  
 
From the results of TEM and FESEM, it could be found that OA-MNPs had a mean 
size at 10 nm with a good size distribution. After coating with PGMA, core-shell 
structured nanoparticles containing epoxy function at the surface (PGMA-MNPs) was 
(c) 
(d) 
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formed. Particles maintained core-shell structure during further modification by 
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Figure 5-5 FESEM of (a) GMA-MNPs, (b) EDA-MNPs, (c) GA-MNPs, (d) Ni-NTA-MNPs; TEM of (e) 




From the FTIR spectra, the characteristic absorption of epoxy group (979 cm
-1
), 
amino group (1651 cm
-1
), and aldehyde group (1716 cm
-1
) were observed for PGMA-
MNPs, EDA-MNPs, and GA-MNPs, respectively. The introduction of NTA to the 
MNPs was evidenced by a significantly increased absorption at 3375 cm
-1
 in the FTIR 
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Figure 5-6 FTIR of (a) OA-MNPs, (b) GMA-MNPs, (c) EDA-MNPs, (d) GA-MNPs, (e) Ni-NTA-MNPs 
 
Table 5-1 Summary of functions from FTIR 
symbol wavenumber (cm-1) functional group nanoparticles 
a 1701 C=O stretch in oleic acid OA-MNPs 
b 3000 O-H stretch in oleic acid OA-MNPs 
c 2850-2916 Fe-O-Fe stretch OA-MNPs 
d 1732 C=O stretch in GMA PGMA-MNPs 
e 979 epoxy group189 PGMA-MNPs 
f 1651 N-H EDA-MNPs 
g 1716 C=O stretch in aldehyde GA-MNPs 
h 1716 C=O stretch in carboxylic acids Ni-NTA-MNPs 




The loading of Ni could be verified by using EDX. From Figure 5-7, it could be 
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NTA-MNPs. Besides, there is no such peak in the EDX profile of NTA-MNPs. These 





Figure 5-7 EDX of (a) NTA-MNPs, (b) Ni-NTA-MNPs 
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The nano-biocatalysts reached a specific loading capacity of 146 mg protein/g MNPs, 
corresponding to 82 % of the maximum theoretical monolayer loading based on the 
calculation using the particle surface area. In order to verify the selectivity of the 
immobilization, different concentrations of imidazole solution were used to elute 
stEH1-Ni-NTA-MNPs. The eluates were analyzed by using SDS-PAGE. As shown in 
Fig. 2, only the his-tagged stEH1 (the thick band around 30 kDa) was observed in the 
eluates from 10-250 mM imidazole solution, and no other protein bands were visible 
in the eluates using 0-250 mM imidazole. These results suggested that his-tagged 
stEH1 was selectively immobilized on Ni-NTA-MNPs and other proteins in CFE 
were not immobilized. Thus, one-pot purification and immobilization of his-tagged 
enzyme was successfully achieved by using Ni-NTA-MNPs via affinity attachment.  
 
 
Figure 5-8 SDS-PAGE of purification and elution his-tagged stEH1. lane 1: protein marker; lane 2: CFE 
of Pichia pastoris producing his-tagged stEH1; lane 3: supernatant after immobilization with Ni-NTA-
MNPs; lane 4-9: eluate from stEH1-Ni-NTA-MNPs by washing with  imidazole solution at different 
concentration 
 
5.3.3 Theoretical Calculation 
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The theoretical loading amount of enzymes on MNPs was estimated based on similar 
model described in Chapter Four. In addition, the amount of released enzyme was 
calculated based on the dissociation constant between six his-tag and Ni-NTA 
functional group.  
 
5.3.3.1 Loading of Enzymes on Ni-NTA-MNPs 
 
A theoretical calculation was made for estimating the total weight of epoxide 
hydrolase loaded on single Ni-NTA functionalized nanoparticle. The calculation was 
similar as described before in Chapter Four. From TEM result of PGMA-MNPs, we 
could hypothesize that the core-shell structured particle possesses a core size at 20 nm 





The Mw of stEH1 is around 37.1 kDa with diameter at 6 nm.
191
 The length of linker is 
estimated as 3 nm. After simple calculation, the specific surface area is 104 m
2
 / g. 
Total stEH1 number on single MNPs is around 380. The weight of single MNPs is 
1.31* 10
-16
 g. Finally, the maximum specific enzyme loading amount is 178 mg 
stEH1 / g MNPs, which is the ideal case when considering spatial hindrance with 
monolayer loading.  
 
Based on the experimental results, the immobilization of stEH1 is 146 mg stEH1 /g 
support. From the value of single particle weight and stEH1 molecular weight, about 
311 stEH1 molecules were bonded on single EDA-MNPs, which covers 82 % surface 
area of the nanoparticles. 
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The size distribution of the synthesized particle is quite narrow, which indicates that 
the overall size of the nanoparticle is stable. If the magnetic core decreased to 10 nm 
(50 % decrease), and with maintained size at 60 nm, the weight of this single particle 
will decrease to 1.15 * 10
-16
 g. As the specific surface area is the same as previous 
calculation, the maximum loading capacity will increase to 202 mg stEH1 / g MNPs, 
which increases 13 %. This shows that this theoretical calculation is quite robust 
without much bias of particle selection.  
 
5.3.3.2 Released Enzyme 
 
The relationship of the release kinetics could be presented in Equation 5-1, where [P], 
[L] and [C] represent the molar concentrations of the protein, ligand and complex, 
respectively. The definition of dissociation constant (Kd) could be presented in 
Equation 5-2. Kd between Ni-NTA functional group and 6×his-tagged protein was 




 In current biotransformation system presented in 
this thesis, initial concentration of immobilized enzyme complex [I] is 9.21×10
-6
 M. 
If in each cycle, the system could reach equilibrium, the released free protein amount 
[X] could be calculated by Equation 5-3, which is 1.91×10
-9
 M. This means that the 
release of free enzyme is only 0.02 % of the total immobilized enzyme after one 
equilibrium cycle, which could be negligible. 
 
      C                 P  +  L  (Equation 5-1) 
 
  (Equation 5-2) 
 
  (Equation 5-3) 
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5.3.4 Performance of Nano-biocatalyst in Racemic Resolution 
 
In order to investigate the activity and recyclability of stEH1-Ni-NTA-MNPs, 
enantioselective hydrolysis of racemic 2-(4-chlorophenyl)oxirane 1 was selected as 
the target reaction
193
. This biohydrolysis reaction catalyzed by stEH1 belongs to 
kinetic resolution, where two enantiomers showed different rates in the reaction. 
Thereby creating an excess of the less reactive enantiomer, and conversion around 50 
% is desirable to make high ee of the less reactive enantiomer shown in Figure 5-9.  
 
stEH1-Ni-NTA-MNPs containing 0.342 mg protein was added to 1.0 mL 0.1 M 
phosphate buffer (pH = 8.0) containing 10 mM epoxide 1, and the mixture was 
incubated at 30 rpm and 30 °C for 2 h. For comparison, same amount of his-tagged 






Figure 5-9 Hydrolysis of 1 to 2 by using stEH1-Ni-NTA-MNPs 
 
The concentration and ee of 1 and 2 at different time points for both cases were 
analyzed by HPLC, and the time course of product concentration was given in Figure 
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5-10. The specific activity for the first 10 min of nano-biocatalyst was 570 U/g 
protein, being 80 % of its free enzyme activity (710 U/g protein). The reaction rate 
was faster for the first 20 min due to the faster hydrolysis of (S)-1, and became slower 
due to the slower hydrolysis of the remaining (R)-2.   
 
In the case of using immobilized stEH1, the ee of 1 reached > 99 % (R) at 53 % 
conversion after 40 min shown in Figure 5-11 and Figure 5-12. This enantiopurity is 
as same as that of free enzyme,
193
 suggesting no change of enzyme catalytic 
selectivity after immobilization. This also verifies the hypothesis that affinity 
immobilization of enzyme on MNPs may possess a site-oriented attachment and thus 
maintain the original enzyme conformation. 
 
 
Figure 5-10 Time course of the hydrolysis of 1 to 2 with nano-biocatalyst stEH1-Ni-NTA-MNPs and 
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Figure 5-11 ee of 2-(4-chlorophenyl)oxirane for free and immobilized stEH1 at different time intervals 
 
 
Figure 5-12 Normal phase HPLC results for immobilized enzyme after 40 mins’ reaction 
 
In 20 mL scale of biotransformation, ee > 99 % could be reached after 60 min’s of 
reaction (Figure 5-13). This also demonstrated the synthetic potential of this nano-
biocatalyst. After purification by using hexane to extract the solution, 10.1 mg (R)-1 
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Figure 5-13 ee and conversion of 2-(4-chlorophenyl)oxirane in 20 mL reaction 
 
5.3.5 Reuse and Recyclability of Nano-biocatalyst 
 
 
Figure 5-14 Vibrating sample magnetometer (VSM) of Ni-NTA-MNPs 
 
Ni-NTA-MNPs behaved superparamagnetically, as shown in the vibrating sample 
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The nano-biocatalyst could also be recycled and reused by using an external magnetic 
field shown in Figure 5-15 in five minutes as a batch separation. As for large volume 
of nanoparticle suspension, it is ideal to utilize internal magnet, or to use external 
high gradient magnet to generate stronger forces for a continuous separation.  
 
 
Figure 5-15 (a) Suspension of stEH1-Ni-NTA-MNPs; (b) separation of stEH1-Ni-NTA-MNPs by 
external magnetic field 
 
 




























No. of Cycles 
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The recycling and reuse of stEH1-Ni-NTA-MNPs were examined by using the same 
reaction conditions for 40 min. After each cycle, the MNPs were separated by using 
an external magnetic field, and 1 mL fresh buffer containing 10 mM substrate 1 was 
added to run a new cycle of biotransformation.  As shown in  
Figure 5-16, the nano-biocatalysts remained 80 % productivity after eight cycles of 
biotransformation. 
 
5.4 Concluding Remarks 
 
In summary, a facile method for the fabrication of recyclable and active nano-
biocatalyst by combining the purification and immobilization of a six histidine-tagged 
enzyme from cell free extract in one pot with Ni-NTA functionalized magnetic 
nanoparticle was developed.  
 
In order to demonstrate the idea, several magnetic particles similar with Chapter Four 
were developed, which were surfactant protected iron oxide crystals, core-shell 
structured epoxy carried MNPs, and the amino functionalized nanoparticles. With the 
purpose of achieving site-specific loading, the particles were further modified with 
aldehyde group, NTA group, and Ni-NTA group without significant change of size 
and structure. Finally, the stable particle was synthesized to have a core-shell 
structure with size of 80 nm, consisting of multiple OA-coated iron oxide MNPs as 
the core, stable PGMA as the shell, and Ni-NTA as the surface function. This overall 
synthetic route provided an easy way to synthesize MNPs with complex functions.  
 
By using Ni-NTA functionalized magnetic nanoparticle as anchor, a his-tagged stEH1 
could be effectively attached and selected from the cell-free extract with the existence 
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of other unwanted proteins. This step accomplished the site-specific loading of the 
enzyme on nano-suppots by its terminal his-tag group. All of the immobilized 
enzyme are well-oriented after immobilization. So the immobilization of his-tagged 
stEH1 from the cell-free extracts on the particle is highly selective, it also gave a very 
high specific enzyme loading capacity of 146 mg protein/g MNPs. This could be 
further attributed to the high surface area to volume ratio of nanoparticles. The 
attached enzyme after loading could be directly used for further biocatalysis. A one-
pot purification and immobilization process was achieved. This methodology could 
be generally applicable to other types of enzymes for facile preparation of recyclable 
and active nano-biocatalysts from cell-free extracts in one-pot. It is also a 
immobilization methodology for enzyme site-orientation immobilization. 
 
The immobilized enzyme exhibited 80 % activity and the same enantioselectivity of 
the free enzyme in the hydrolysis of racemic 2-(4-chlorophenyl)oxirane. This could 
be attributed to the site-specific loading on the nano-support, where the activity of the 
enzyme was less interfered. Besides, the nano-biocatalyst was easily separated under 
external magnetic field, and retained 80 % productivity after recycling and reuse for 
eight times. This demonstrated the advantages by using the magnetic particles for 
decreasing the overall catalytic cost. The product was also separated and purified 
with > 99 % ee, which indicated the usability for synthesizing enantiopure chemical 
intermediate by recyclable nano-biocatalyst.  
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6 PRODUCTION OF BIODIESEL FROM GREASE TRAP OIL BY 





The rigid energy demand worldwide and environmental concerns call for alternative 
renewable energy sources.
194,195
 Biodiesel is a perfect candidate to fulfill this task, 
with the advantages of generating fewer pollutants, sourcing from renewable 
materials, and obtaining good combustion features.
155,196
 However, the price of 
traditional feedstock for producing biodiesel, like soybean oil
197
 (1200 US$/ton) or 
palm oil
198
 (1000 US$/ton), is too expensive to be commercialized compared with 
petroleum diesel price (88 US$/ton)
199
. Besides, the competition of producing fuel 




To solve this dilemma, low cost feedstock should be developed, especially waste oil 
containing the essential triglyceride for producing biodiesel.
168,201
 This approach 
could solve the related environmental issues and generate energy at the same time. 
Grease trap oil (eg. brown grease) could be a good candidate to produce biodiesel for 
its zero or negative price. It is also abundant in urban area, especially in developed 




However, one technical difficulty for using this kind of low-price feedstock is its high 
free fatty acid (FFA) content inside the oil.
203
 For grease trap oil (GTO), the FFA 
amount is normally higher than 15 % w/w, where the conventional base catalysts fail 
to perform well due to saponification.
204
 While the low activity of acid catalyst and 
the difficulties in recycling and environmental pollution caused by the catalysts are 
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also remaining technical challenges by using high FFA feedstock.
205
 In contrast, 
enzymatic catalysts showed good potential in using of grease trap oil.
206
 The only 
concern is the high cost and poor stability of free enzyme, which make the process 
unrealistic.
159
 One way to solve the problem is to immobilize enzyme on solid 
supporting materials. Generally, mesoporous structured materials are used to achieve 
this goal. Novozym 435 is one of the most famous immobilized enzymes using in this 
field.
207,208
 However, the pores on its surface could be easily blocked by glycerol 
produced in this process, which leads to the deactivation of the lipase immobilized 
inside the pores.
209,210
 Besides, the dispersibility of the beads is quite poor, where the 
mass transfer of the reaction in viscous oil phase is limited. 
 
In order to solve all above mentioned problems, we propose to use MNPs as the 
loading material to immobilize enzyme in Chapter Six. There are four advantages to 
use this magnetic nano-system for producing biodiesel from grease trap oil. First, the 
extreme high surface areas to volume ratio of nanoparticles provide the possibility of 
a rather high enzyme loading capacity, which further improves the performance of the 
nano-biocatalyst. Second, the good dispersibility of the immobilized enzyme could 
minimize mass transfer limitation and improve productivity during esterification and 
transesterification. Third, enzyme after immobilization could perform in a wide range 
of pH value and the thermal stability of the enzyme can also be improved. This will 
help to adapt the catalyst to be suitable for use under fluctuated quality of feedstock. 
Finally, the magnetic property of these nanoparticles could facilitate efficient 
separation of the catalyst after reaction, even in non-Newtonian fluids like oil mixture 
with a very high viscosity. This will help to dramatically decrease the enzyme cost in 
the process, as well as to facilitate an easy separation of biodiesel product. 
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The objective of this chapter is to establish an approach for synthesizing high-
performance biocatalyst, with MNPs as supporting material, and a commercial 
available purified lipase as functional catalyst, for the application of esterification and 
transesterification of grease trap oil to produce biodiesel. The focus of this chapter is 
to solve the problem of high FFA in grease by esterification, since transesterification 
can be further accomplished by using base catalyst after the treatment of enzymatic 
esterification.  
 
6.2  Methodology 
 
6.2.1 Overall Concept 
 
 
Figure 6-1 Overall concept for using immobilized enzyme on MNPs to produce biodiesel 
 
The overall concept of Chapter Six is presented in Figure 6-1. Enzymes will be 
attached on functionalized MNPs, and used for two catalytic reactions consecutively. 
In esterification, free fatty acid (FFA) will react with methanol to produce fatty acid 
methyl ester (FAME). In transesterification, triglyceride will also react with methanol 
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to produce FAME and glycerol. Both of the reactions are catalyzed by enzymes 
immobilized on MNPs. 
 
6.2.2 Experimental Design 
 
6.2.2.1 Flowchart of Particle Synthesis 
 
Figure 6-2 shows three different enzyme immobilization protocols by using PMMA-
MNPs, PS-MNPs and PMMA-PGMA-MNPs, EDA-MNPs and GA-MNPs. The first 
two particles PMMA-MNPs and PS-MNPs for immobilizing enzymes are based on 
physical adsorption only. The loading of enzyme on PMMA-PGMA-MNPs relies on 
both physical adsorption and covalent binding via epoxy group. EDA-MNPs and GA-
MNPs systems will be only used for covalent binding. 
 
Figure 6-2 Protocols for fabrication of magnetic nano-biocatalyst with lipase 
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6.2.2.2 Characterization of Nano-biocatalyst 
 
The size and the shape of magnetic nanoparticle were characterized by using TEM 
and FESEM. The catalytic performances of magnetic nano-biocatalyst (lipase-MNPs) 
were identified by using enzymatic reaction, monitoring the formation of product, and 
the decrease of acid value. The nano-biocatalyst was also reused and recycled to 
perform catalytic reactions. 
 
6.3 Results and Discussion 
 
6.3.1 Particle Synthesis and Characterization 
 
Five types of MNPs were synthesized as described in Figure 6-2 by using in situ 
polymerization of iron oxide magnetic nano-crystals with specific monomer under the 
catalysis of an initiator ammonium persulfate. For PMMA-MNPs, methyl 
methacrylate containing vinyl group in the structure, was used to perform the 
polymerization. The polymerization reaction was very fast. As a result, iron oxide 
nano-crystals were well-coated by the polymer shell. PS-MNPs were synthesized 
with similar method as PMMA-MNPs. Due to the surface tension difference, a water-
melon shaped nanoparticle with distributed iron oxide was formed. It is hypothesized 
that small individual iron oxide was firstly coated by poly-styrene. In a short time, 
several small polymer coated particles in vicinity coupled and formed bigger particles. 
This could also explain the wide distribution of the PS-MNPs. PMMA-PGMA-MNPs 
were co-polymer coated iron oxide nanoparticle. The two different monomers have 
similar properties regarding the structure. The only difference is the carriage of epoxy 
group on the monomer glycidyl methaacrylate.  It was found that the available epoxy 
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group (890 μmol/g support, reported in §4.3.1.2) was in large excess compared with 
amount of enzyme (eg. 100 mg enzyme/g support, which is 3 μmol enzyme/g support) 
should be loaded on pure PGMA-MNPs. The addition of the other non-epoxy carried 
monomer could help to adjust the total quantity of functional group to modify the 
surface property. As reported in previous chapter, PGMA-MNPs were also 
synthesized. Two particles, which possessed amino group or aldehyde group, were 
further synthesized. For the entire particles synthesized, it could be found that all iron 
oxide crystals were coated by polymer shell, with the synthetic yield > 90 % based on 
the calculation of the nano-crystals. 
 
Figure 6-3 presented the TEM and FESEM of MNPs. It can be seen that OA-MNPs 
have size around 10 nm. Different polymer shells were used to coat these 
nanoparticles. PMMA-MNPs showed multiple core-shell structures, and the core size 
was about 40 nm, with shell thickness at 10 nm. PS-MNPs exhibited a structure with 
well-distributed iron oxide seeds. The size of the PS-MNPs was bigger, which was 
round 200 nm to 300 nm. PMMA-PGMA-MNPs showed core-shell structure similar 
to PGMA-MNPs. The size of the particle was around 80 nm. In the TEM image, the 
particles seems to be linked together but actually not, which was caused by mild 
melting of concentrated sample when heating by the high energy beam. Actually, the 
particles were well-dispersed in solution with narrow distribution (DPI < 0.01). EDA-
MNPs and GA-MNPs showed similar structure as shown in Chapter Four, which 
have size around 60 nm.   
 
 














Figure 6-3 TEM of (a) OA-MNPs, (b) PMMA-MNPs, (c) PS-MNPs, (d) PMMA-PGMA-MNPs, (e) 
PGMA-MNPs, (f) EDA-MNPs; FESEM of (g-h) Novozym 435, (i) Lipozyme, (j) PMMA-MNPs, (k) 
CALB-PMMA-MNPs, (l) CALB-PS-MNPs, (m) CALB-EDA-MNPs, (n) CALB-GA-MNPs 
 
The surface of Novozym 435 and Liposyme were also characterized by FESEM. It 
could be seen from Figure 6-3 that Novozym 435 had a mesoporous structure with a 
rather flat surface, while Liposyme had a rough surface without any pores. For our 
synthesized particle, like PMMA-MNPs, there was no nano-sized pore on the smooth 
  
 (m) (n) 
(k) (l) 
(j) (i) 
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surface.  Each of the particles will attach enzyme individually without any 
interference. The shape of the particles did not change much after loading of lipase 
(eg. CALB) as shown in the FESEM images. 
 
6.3.2 Enzyme Immobilization and Loading Efficiency  
 
6.3.2.1 Study of Enzyme Structure 
 
CALB contains two parts: protein A and protein B. Each of them contains 317 amino 
acids and nine lysine groups in total. Those lysine groups are well-distributed around 
the enzyme as shown in Figure 6-4. Thus, the enzyme can be attached by using 
covalent binding interacting with free amino group on the enzyme surface. However, 
it is hardly to control the enzyme orientation on the supporting materials during 
random attachment. If the lysine groups near active site were immobilized, the 
substrate would be difficult to access to the active center of the enzyme, which may 
result in a decrease of enzyme activity.  
 
Figure 6-4 3D Structure of CALB (light yellowish parts are lysine) 
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The current application for immobilized enzyme is biocatalysis in oil phase (organic 
solvent) instead of in aqueous phase. This provides the possibility to use physical 
adsorption instead of covalent binding for enzyme immobilization. Enzyme is 
generally not soluble in organic solvent, so the release of enzyme by physical 
adsorption from the surface of nanoparticles will be limited.
211
 The recyclability of 
hydrophobic interacted enzyme in oil phase is easy as well. During recycling and 
reuse, enzyme will not be easily released, and there will be less interference from the 
hydrophobic reaction environment. Besides, lipase adsorbed on hydrophobic surface 
has been approved to have the same orientation with optimized activity.
212
 These 
good features will qualify immobilized lipase via physical adsorption to perform well 
in the catalytic reaction.  
 
6.3.2.2 Theoretical Enzyme Loading 
 
A theoretical calculation was made for estimating the total number of enzyme on 
single particles after immobilization based on a 100 nm particle. From TEM results of 
GMA-MNPs, we could hypothesize that the core-shell structured particle possesses a 
core size at 30 nm and the total size is 100 nm. From X-ray results in literature, the 
real size of CALB is 6.21 × 4.67× 9.21 nm. In this model, enzyme molecule is 
considered as spherical size with a diameter at 9 nm, which is perfectly packed on the 
particle surface with monolayer distribution. The footprint of each enzyme is 
supposed as rectangular footprint as presented in previous chapter. 
 
Several important parameters are calculated and estimated from the model, including 
the specific surface area, total enzyme number on single MNPs, weight of single 
MNPs, and specific Enzyme loading amount.  
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In order to get specific number of those parameters in the model, simple estimation 
was made. ρc = 5.18 g/cm
3
 (density of Fe3O4), while ρs = 1.14 g/cm
3
 (density of poly 
(GMA)). The Mw of CALB is around 33 kDa. The length of linker is estimated as 1 
nm. After simple calculation, total CALB number on single MNPs is around 403. The 
maximum specific enzyme loading amount is 33 mg CALB / g MNPs, which 
considers spatial hindrance with monolayer adsorption as hypothesis. 
 
6.3.2.3 Immobilization of CALB on MNPs 
 
Table 6-1 Loading capacity of CALB on MNPs 





PMMA-MNPs-30 Physical Adsorption 30 147.4 
PMMA-MNPs-4 Physical Adsorption 4 45.3 
PS-MNPs-30 Physical Adsorption 30 200.0 
PS-MNPs-4 Physical Adsorption 4 200.0 
EDA-MNPs-30 Covalent Binding 30 15.0 
GA-MNPs-30 Covalent Binding 30 18.6 
GA-MNPs-4 Covalent Binding 4 16.6 
 
Based on the analysis of protein structure and its application, CALB was immobilized 
by using five different particles in large scale after optimize the immobilization 
conditions in small scale. In the immobilization system (20 mL), 15 mg particles and 
3 mg CALB were mixed in buffered solution. Two different temperatures (4 ºC and 
30 °C) were applied for these five different particles resulting in ten different CALB-
MNPs for 24 hours at pH 7.0. Among these ten conditions, seven conditions have 
positive immobilization results (others are negative or zero due to very little 
immobilization amount). The results are shown in Table 6-1. 
Chapter 6 Production of Biodiesel by Lipase Immobilized Magnetic Nano-biocatalyst         124 | P a g e  
It can be seen that for PMMA-MNPs, more enzyme was immobilized at 30°C than at 
4°C, probably due to the favored thermodynamics of physical adsorption at higher 
temperature. For PS-MNPs, the loading capacity was as high as 200 mg/g for both 
conditions. This value is two times of Novozym 435 (100 mg enzyme/g beads
18
), a 
commercialized catalyst consisting of macroporous acrylic resin with physical 
absorbed CALB. This could be attributed to the small size of nanoparticle and its high 
surface area to volume ratio. These particles were further freeze-dried to remove 
water before applying in the esterification of FFA in grease trap oil. 
 
For the particles PMMA-PGMA-MNPs which have two functions, the results of 
immobilization were not positive. The other four conditions by GA-MNPs and EDA-
MNPs via covalent binding also have rather low specific immobilization capacity, 
and all of them are less than 20 mg/g, this value reached 45-57 % of theoretical 
amount based on previous calculation considering spatial hindrance. This could be 
due to the orientation of enzyme on MNPs via covalent binding is different with 
adsorption. After loading of the monolayer of enzyme by chemical binding, the 
exposed surface of enzyme and particle did not favor multiple layer of enzyme 
immobilization via adsorption. 
 
In contrast, the loading amount by adsorption was much higher than this value. This 
showed that for physical adsorption was via hydrophobic interaction, and multilayer 
of adsorption was achieved. These seven particles with immobilized CALB were 
further freeze-dried and applied for esterification and transesterification. 
 
6.3.3 Esterification of FFA in Grease by Immobilized CALB 
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Biotransformation of grease to biodiesel was conducted to analyze the performance of 
the nano-biocatalyst. Esterification was the main focus for this process. CALB-
PMMA-MNPs-30 was used to optimize the enzyme loading for the biotransformation 
of  GTO. It could be seen from Figure 6-5 that 1 % of particle loading had a good 
performance towards esterification. Within 1 hour, the acid value dropped down from 
17% to less than 6 %. Decreasing the particle loading further to 0.50 %, 0.20 % and 
0.10 %, the reactions rate dropped with remaining acid value > 10  % w/w. While 
increasing the particle loading to 1.95 %, the reaction speed did not increase, which 
indicated enzyme loading was not a limiting factor in the catalytic system in that case.  
 
 
Figure 6-5 Acid weight percentages by esterification using MNPs. Conditions: oil weight 0.7 g; temp. 30 
ºC; time 1h; FFA: MeOH= 1:1  
 
Esterification of acid compound in GTO by CALB-MNPs, Novozym 435 and 
Liposyme were studied. Figure 6-6 presented acid weight percentages after 3h’s 
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Figure 6-6  Acid weight percentages by esterification using MNPs, Novozym 435 and Lipozyme. 
Conditions: oil weight 1.7g; temp. 30ºC; time 3h; particles: grease=1 % w/w; FFA: MeOH= 1:6 
 
 
Figure 6-7 Performance of adsorbed CALB on MNPs for esterification of the free fatty acid in grease 
trap oil. Conditions: oil weight 1.0g; temp. 30ºC; time 3h; particles: grease=1 % w/w; FFA: MeOH= 1:6 
 
Time courses of the different CALB-MNPs and Novozym 435 were given in Figure 
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higher activity than particles at 30 ºC. Among two different particles, PS-MNPs 
showed a 1.2 times higher ability than PMMA-MNPs in performing esterification. 
Within 1h, the acid value dropped to 2 % by using PS-MNPs-4. In practice, the acid 





The initial rate of Novozym 435 in reaction was faster than the other two 
nanoparticles synthesized in 30 ºC. However, after half an hour, Novozym 435 could 
be hardly maintaining the efficiency for long time reaction without washing away of 
the produced glycerol. In contrast, there was no similar phenomenon occurred for all 
MNPs with immobilized enzyme. The MNPs with immobilized enzyme could have a 
better performance for long-term operation. 
 
In addition, comparing CALB-PMMS-MNPs-4 (45.3 mg/g) with Novozym 435 (100 
mg/g), it can be seen that the MNPs immobilized CALB has more than two times 
higher specific enzyme activity than commercialized Novozym 435 for esterification 
of free fatty acid in the initial 0.5 hour. This indicated that MNPs can help to maintain 
the enzyme activity after immobilization. The small size of the MNPs could also 
facilitate the enzyme to maximize its activity. 
 
In the protocol by using covalent binding, the performance of GA-MNPs was better 
than the performance of EDA-MNPs. This may be due to milder condition of GA-
MNPs than EDA-MNPs, which had the addition of gluteradehyde in situ. 
Glyteradehyde may decrease the enzyme activity via random crosslinking. However, 
it should be also noticed that the loading capacity for these covalent protocols are less 
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than 20 mg/g. Comparing with the large loading of adsorption protocol, the 
esterification efficiency in terms of single enzyme was similar.  
 
 
Figure 6-8 Performance of covalent bonded CALB on MNPs for esterification of free fatty acid in grease 
trap oil. Conditions: oil weight 1.0g; temp. 30ºC; time 3h; particles: grease=1 % w/w; FFA: MeOH= 1:6 
 
6.3.4 Reuse and Recyclability of Nano-biocatalyst 
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Recycle and reuse of these nano-biocatalysts were studied based on the esterification 
of grease containing free fatty acid. The remaining free fatty acid was titrated by 
standard base.  
 
 
Figure 6-10 Recycle of CALB-PMMA-MNPs-4 for esterification of FFA in GTO 
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It could be found that CALB-PMMA-MNPs-30 and CALB-PMMA-MNPs-4 showed 
good performance in six cycle, which had conversion above 80 % in each cycle. 
CALB did not peel off in each cycle under the hydrophobic environment as the 
catalytic performance maintained during recycling. The conversion in each run of 
Novozym 435 was not as good as MNPs.  
 
6.3.5 Analysis of FAME by GC-MS 
 
The produced FAME was analyzed by using GC-MS. It could be found that there are 
totally four kinds of methyl ester, which are C16:0, C18:1, C18:2, and C18:0 shown 
in Figure 6-12. Comparing with diesel from crude oil, the average carbon chain is 




Figure 6-12 GC-MS results of produced FAME 
 
Transesterification of GTO by using CALB-MNPs were performed to verify the side 
reaction by using magnetic nanocatalyst during esterification. The weigh percentage 
of particles in the reaction mixture was 1 %. The reaction was monitored for several 
hours by analyzing the sample with GC using INNOWAX column and hexadecane as 
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internal standard. However, the production of water by esterification as well as the 
addition of methanol inhibited the reaction. It can be seen that during esterification 
process for decreasing acid value, transesterification could also occur at the same 
time. However, the reaction rate was very slow. It can only convert about less than 
10% of triglyceride in the grease trap oil within the three hours. 
 
6.3.6 Comparison between PS-MNPs-CALB and Novozym 435 
 
 
Figure 6-13 Comparison of nano-biocatalyst (PS-MNPs-lipase) with Novozym 435 after half an hour’s 
reaction 
 
MNPs with immobilized CALB could disperse well in oil phase. Figure 6-13 
presented the difference between CALB-PS-MNPs and Novozym 435 with grease 
trap oil after half an hour’s reaction. It could be clearly seen that Novozym 435 
precipitated in the bottom of the tube, while CALB-PS-MNPs form a homogeneous 
mixture with oil at the same catalyst loading weight percentage. 
 
In contrast, there was no similar phenomenon occurred for all MNPs with 
immobilized enzyme. It maintained the dispersibility during long-term reaction. This 
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phenomenon also indicated the potential advantages to enhance the mass transfer of 
the substance in the reaction by using magnetic nanocatalyst. 
 
6.4 Concluding Remarks 
 
MNPs with different surface functions and structures were designed and synthesized 
with the purpose of attaching CALB for biodiesel production from grease trap oil. 
 
Five different particles were synthesized based on in situ polymerization on the 
surface iron oxide nano-crystals. Most of the MNPs presented core-shell structure 
with the size from 50 nm to 80 nm, while PS-MNPs showed a well-distributed seeds 
structure with the size of 200 nm to 300 nm. EDA-MNPs carried amino group, and 
GA-MNPs carried aldehyde group. Two other particles, PMMA-MNPs and PS-MNPs, 
possess no specific chemical function, but with hydrophobic surface. The surface of 
PGMA-PMMA-MNPs was a mixture of epoxy group and hydrophobic group. 
 
As described above, three different protocols were used based on the nature of 
nanoparticle surface properties. Covalent attachment of CALB was applied for EDA-
MNPs and GA-MNPs. However, due to the abundance of lysine groups on CALB, 
the orientation of CALB could not be well-controlled. The loading of the enzyme 
could only reach single layer, since the functional group on the nanoparticle surfaces 
was limited, and secondary layer by adsorption was not favored due to the orientation 
of first layer enzyme. This resulted in rather low enzyme loading capacity. PMMA-
MNPs and PS-MNPs showed high enzyme loading capacity based on physical 
adsorption. This best loading capacity is two times higher than the reported Novozym 
435 loading (100 mg CALB/g resin). A multiple layer adsorption may occur based on 
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theoretical calculation. Epoxy group did not react well with the surface function of 
lysine. It could be possible that the existence of hydrophobic group on the particle 
surface may interact with other region of the enzyme and a repulsive force decreased 
the loading capacity of enzyme.   
 
Different particles under seven conditions with positive immobilization results were 
further used to perform esterification. It could be seen that with 1 % w/w nano-
biocatalyst in grease trap oil, more than 95 % of free fatty acid would be transferred 
to fatty acid methyl ester within 3 hours’ reaction. CALB-PMMA-MNPs-4 showed 
more than two times higher specific enzyme activity than Novozym 435 in 
esterification of free fatty acid. After decrease of the acid value of grease trap oil to 
an acceptable range (< 2 % w/w), transesterification of triglyceride could be easily 
achieved by using traditional base catalysts. It should be feasible to use nano-
biocatalyst to perform esterification in the first step of biodiesel production. 
 
These nanoparticles with immobilized CALB were also reused and recycled to 
decrease the acid value in grease trap oil, only targeting esterification. The nano-
biocatalysts were reused for more than six times without dramatic decrease of enzyme 
activity. Besides, most of the immobilized enzyme on MNPs showed better 
performance comparing with Novozym 435, which indicated the advantages by using 
nano-biocatalyst.   
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MNPs immobilized with different enzymes as catalysts were successfully synthesized, 
characterized, and utilized in several biocatalytic reactions, including green oxidation 
and biodiesel production. These nano-biocatalysts shown versatile catalytic functions, 
high activities, long-term stabilities, fine dispersibilities in various solvents, and good 
recyclabilities, being promising biocatalysts for in vitro biotransformation. 
 
More specifically, three different examples with focusing on establishment of 
nanoparticle system, optimization and generalization of immobilization on MNPs, 
and bio-catalytic application of MNPs with immobilized enzymes were demonstrated. 
These examples proved the novel concept of engineering of different types of 
magnetic nano-biocatalyst. 
 
Firstly, a core-shell structured magnetic nanoparticle with immobilized CPO was 
fabricated for enantioselective sulfoxidation. Core-shell structured superparaMNPs 
with functional polymer coating layers were prepared by facile co-precipitation 
method followed by in situ polymerization. Immobilization of CPO, an expensive 
oxidase with H2O2 as an oxidant was achieved via covalent interactions between 
nanoparticle supports and enzyme lysine groups, giving maximal specific loading 
capacity at 16.1 mg/ g MNPs. According to a theoretical calculation, it corresponded 
to 12 % occupation of enzymes on the particle surface area. The resulting nano-
biocatalyst showed the same apparent activity and Km of the free enzyme. The nano-
biocatalyst was used for green oxidation of thioanisole to give (R)-methyl phenyl 
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sulfoxide in > 99 % e.e., where the catalyst was successfully recycled via magnetic 
separation for 11 times without dramatic decrease of enzymatic activity and chiral 
selectivity. 
 
Secondly, one-pot purification and immobilization of a his-tagged epoxide hydrolase 
on Ni-NTA modified MNPs was developed for enantioselective hydrolysis of racemic 
2-(4-chlorophenyl)oxirane. This method provided a new concept of specifically 
immobilizing target enzyme from cell lysate on magnetic nano-supporting materials 
in one pot. The immobilized enzymes showed 80% activity of the free enzyme in 
solution, while maintaining the same regio- and enantio-selectivity during catalysis. 
This type of catalyst was recycled for 8 times with 80 % of activity in the last cycle. 
These results indicated that the nano-biocatalyst could minimize the change of the 
enzyme structure with a site-specific affinity immobilization. The enantiopure 
product was easily purified from the system, showing the advantage of in vitro 
biocatalysis and its potential application in industry. 
 
Thirdly, CALB was immobilized on five different MNPs by using three major 
protocols (covalent, physical adsorption and hybrid) for esterification of free fatty 
acid in the process of biodiesel production from grease trap oil. The results 
demonstrated that adsorption protocol was the most suitable method for immobilizing 
enzyme in hydrophobic solvents, and a homogeneous reaction system with magnetic 
nano-biocatalyst was achieved. The use of very small amount of nano-biocatalyst (1 % 
w/w) to decrease the acid value in a short time (1 hour) showed great potential in 
future industrial application.  
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There are several other general contributions in this thesis. Core-shell or watermelon 
structured MNPs with various functions were designed and synthesized in facile ways. 
Frist, magnetic fluid containing super-paramagnetic iron oxide single crystals were 
synthesized by using co-precipitation method with the protection of a kink structured 
surfactant oleic acid. Second, MNPs with a size range from 50 nm to 300 nm were 
synthesized by in situ polymerization on the surface of pre-synthesized iron oxide 
crystals. All the particles behaved superparamagnetically with stable shell, and were 
further modified with surface functional groups: epoxy group, amino group, aldehyde 
group, Ni-NTA group, and hydrophobic group. With these functions, immobilization 
of targeted enzyme was achieved in an elegant manner, maintaining the free enzyme 
activity and selectivity.  
 
The loading amount of the enzymes in all cases demonstrated in this thesis was much 
higher than that of using conventional micro-sized beads. This further verified the 
possibility of achieving high enzyme loading capacity on certain weight of materials 
by using nanoparticles. Nano-biocatalysts also exhibited superior advantages in terms 
of minimizing mass transfer resistance.  
 
Four different immobilization protocols (covalent, affinity, physical adsorption, and 
hybrid) based on different functionalities were explored. Different type of enzyme 
can be immobilized with different immobilization protocol based on the location of 
surface lysines, enzyme hydrophobic regions, special tags, and biocatalytic 
applications. A new affinity protocol with one-pot purification and immobilization 
feature was also developed to simplify the purification step. This method is generally 
useful for other systems, to remove the tedious purification step before 
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immobilization. It dramatically simplifies the immobilization protocol without 
purification of enzymes in advance. 
 
7.2 Recommendations for Future Work 
 
Magnetic nanoparticle with a faster magnetic response could be researched to further 
explore the application of this recyclable system. Separation of rather large amount of 
MNPs should be considered in future study. There are several possible ways to 
achieve this goal: 
1) Controlled clustering of magnetic crystals with proper coating chemistry 
could be used to enhance the overall magnetic property without 
aggregation. 
2) Instead of iron oxide, other magnetic alloy or magnetic materials with 
strong magnetic response could be explored as the core materials of the 
nanoparticles. 
3) Controlled clustering of synthesized particles with smart coating 
materials under the change of external circumstance, for example, pH, 
temperature, shaking style, salt concentration, organic solvent, sugar 
molecule, UV light, and microwave, could be used to temporarily 
aggregate the magnetic particles to increase their response to external 
magnetic field during recycling steps.   
4) Internal magnetic field inside the solution could be applied to enhance the 
magnetic response of the nanoparticles.  
5) Particles with complementary structure of current magnetic nanoparticle 
could be developed to induce the high magnetic response of the whole 
system.  
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More examples based on affinity immobilization protocol could be demonstrated to 
show the advantages of one-pot purification and immobilization. There are several 
possible ways to achieve this goal: 
1) His-tagged CALB or his-tagged CPO can be developed, which could be 
used to demonstrate this idea.  
2) The current dissociation constant Ni-NTA and his-tagged enzyme is 
based on flat surface of loading materials. It could be interesting to study 
the affinity based on different size of MNPs, as well as other nearby 
functions on the particles.  
3) As described in the literature review, there are many protocols for 
achieving site-specific loading. For example, protocol based C-intein and 
N-intein could also be researched in the system of magnetic nanoparticle 
for one-pot purification and immobilization. 
4) A tag library could be constructed. This could include the common 
purification tags and its corresponding interaction surface function on the 
MNPs. For any target enzyme, the tag could be designed and tested by 
using the library to find out the best attachment chemistry. It could also 
combine the concept of microfluidics to make testing chips. 
5) RNA or DNA aptamers library could be generated for a certain enzyme. 
These aptamers could be used for selectively purify and immobilize this 
enzyme by immobilizing on MNPs. 
 
Tandem or cascade catalytic system containing several different enzymes 
immobilized on MNPs could be achieved based on current particle system. There are 
several possible ways to achieve this goal: 
1) Same or different MNPs could be used to attach multiple enzymes. 
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2) The immobilization protocol can be same or different depending on the 
nature of the enzyme. Protocols based covalent, affinity or physical 
adsorption could be used. 
3) Enzymes involved in a metabolic pathway could be immobilized in the 
particle system. The performance of each step could be optimized by 
changing the amount of each enzyme for achieving synergetic effect. 
 
The application of magnetic nano-biocatalyst could be extended to other fields, where 
better dispersibility and recyclability are required. There are several possible ways to 
achieve this proposal: 
1) Biosensor could be a very important application for current magnetic 
nano-biocatalytic system, where enzymes like glucose oxidase could be 
immobilized and used to test glucose concentration with minimal amount 
of blood from patent with diabetes. 
2) Drug delivery involving enzymes or peptides could be another important 
application. These biomolecules can be reversible loaded on magnetic 
nanoparticle and transported to the target tissue by using external 
magnetic field.  
3) Magnetic resonance imaging (MRI) could be another application for 
using MNPs with immobilized enzyme. Certain ligand on the MNPs 
could help to stabilize the image and prolong the image time. It could 
also ease the pain of the patent during dosing by co-immobilize 
therapeutic enzyme on MNPs in situ. 
4) It could be ideal to fabricate magnetic test paper, where the mass transfer 
resistance could be minimized during the reaction, and the testing 
enzyme can be recycled after showing signals.  
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In summary, MNPs with immobilized enzyme could continue to be a hot topic 
for research as well as for industrial application, due to its superior advantages 
compared with conventional catalysts. Further researches are required, with the 
purpose of achieving better performance of the whole system considering the 
particle behavior and the multiple enzyme cooperation. 
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